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Musculoskeletal impairments associated with diabetes mellitus (DM) have been 
disproportionately understudied though they often lead to reported functional limitations and 
disability.  Furthermore, individuals with diabetes mellitus and peripheral neuropathy (DMPN) 
have nearly three times the rate of functional mobility deficits associated with lower extremity 
impairment than their non-diabetic counterparts1,2. The focus of this research is on DM and its 
related complications, specifically the examination of the contribution of a specific gait 
impairment, an excessive external foot progression angle (FPA), on the lower extremity 
impairment cascade of medial neuropathic plantar ulcer (NPU) development and subsequent 
non-traumatic lower extremity amputation in individuals with DMPN (Figure 1).   
 
1.1. Diabetes mellitus:  Healthcare burden and clinical relevance 
1.1.a.  Prevalence.   
Diabetes mellitus (DM) is a chronic and progressive metabolic disease characterized by 
elevated blood glucose secondary to insufficient insulin output and insulin resistance, leading to 
impaired glucose uptake and suboptimal neuromuscular function3,4.  Medical management of 
DM represents a major national and international healthcare burden, with total estimated costs 
of treatment and management of $174 billion in the United States5.  The World Health 
Organization (WHO) estimates a worldwide prevalence of DM of 347 million people4, while the 
Centers for Disease Control and Prevention estimate a prevalence of approximately 25.8 million 
Americans (8.3% of the population)5.   In the United States, 90-95% of those with DM have type 
2 diabetes (T2DM), of which Black/African American (13.1 per 1000), Hispanic/Latino (12.3 per 
1000), and American Indian/Alaska Native (11.8 per 1000) race groups have a 
disproportionately higher prevalence compared with White Americans  (8.7/1000)5.   
1.1.b. Complications of diabetes mellitus.    
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 1.1.b.1.  Peripheral neuropathy.  An observed long-term complication of DM is peripheral 
neuropathy, defined as a clinical diagnosis of peripheral nerve impairment resulting in 
dysfunction affecting the sensory, motor, and autonomic nervous systems6,7.  The proposed 
pathogenesis for the onset and progression of peripheral neuropathy features a complex 
interaction of vascular and metabolic factors that result in ischemic nerve injury8,9.  Peripheral 
neuropathy follows a heterogeneous clinical course with an equally varied manifestation of 
progressive clinical symptoms, and is estimated to affect up to 60-70% of individuals with 
chronic DM in the United States 6, 7,10-12.  The most prevalent form of peripheral neuropathy is 
the distal symmetric polyneuropathy classification in which sensory and motor changes occur 
symmetrically in the lower and upper extremity 10, 13.  This is also referred to as the “stocking 
and glove distribution” of peripheral nerve symptoms13.   Clinical symptoms are insidious and 
progressive in nature, characterized by a transition from acute sensory changes such as varying 
degrees of hyperalgesia (an exaggerated response to a noxious stimulus) and allodynia (a pain 
response to a non-noxious stimulus) to paresthesia (numbness, tingling), abnormal reflexes, 
and muscle performance deficits6.  Diagnostic screening for the presence of diabetic peripheral 
neuropathy includes tests of protective sensation, lower extremity perfusion, and self-
assessments of function6.  The chronicity of peripheral neuropathy is purported to contribute to 
the development of diabetic foot disease, a cluster of lower extremity pathologies that often lead 
to pain, morbidity, loss of function and disability6,14.   
 
1.1.b.2.  Diabetic foot disease.  Diabetic foot disease carries a substantial economic 
healthcare burden.  Treatment and management of diabetic foot disease in the United States 
costs approximately $4.6-13.7 billion annually, and often culminates in non-traumatic lower 
extremity amputation 6,15.   The hallmarks of diabetic foot disease are demineralization and 
structural malalignment of the pedal bones, excessive regional peak plantar pressure, 
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neuropathic plantar ulceration, and acute or chronic foot infection in individuals with DM14.  
There are more than 65,000 non-traumatic lower extremity amputations in adults with DMPN 
annually in the United States, 84% of which are preceded by neuropathic plantar ulcers 
(NPUs)5,16. Sinacore et al (1987) showed that 64-81% of NPUs are located on the medial side of 
the foot compared to the lateral side of the foot17.  
 
1.1.b.3.  Neuropathic plantar ulceration.  The development and recurrence of neuropathic 
plantar ulcers (NPUs) are a significant health and economic burden worldwide.  In the United 
States, an estimated 12 to 25% of adults will develop an NPU18,19.  Furthermore, those with a 
history of NPU have the highest relative risk for re-ulceration or new ulcer development 
(RR=2.46; 95% CI: 1.84-3.29)20.  Peak plantar pressure (PPP) is often used as an index of risk 
for skin injury in individuals with DMPN21,22.  People with DMPN with history of NPU have 
greater PPP in regions of the foot vulnerable to ulceration compared to those with no history of 
NPU23,24.  The combined effects of elevated PPP, limited joint mobility of the foot and ankle, lack 
of somatic sensation in the foot, and impairments in autonomic nerve function that lead to dry 
skin and callus formation contribute to the relative risk of NPU development25.  The 
development and recurrence of NPUs in individuals with DMPN are related to gait adaptations 
that compensate for limited joint mobility and impaired muscle performance of the foot and ankle 
joint complex 26-28.   
 
1.1.b.4.  Gait dysfunction. Individuals with DMPN often exhibit the following gait abnormalities:  
1) decreased gait speed, 2) excessive external FPA or ‘toe-out angle’, and 3) prolonged stance 
time 26,28,29-32.  These gait adaptations have been linked to the protracted timing and magnitude 
of regional plantar stresses in areas of the foot at risk for skin injury in individuals with DMPN 
27,32.  Foot progression angle, or “toe-out angle,” is a spatial gait characteristic defined by the 
orientation of the longitudinal axis of the foot in the transverse plane with respect to the direction 
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of progression during gait33,34.  Previous reports have established normative values for FPA 
magnitude as ranging from 5-9⁰ in older and younger healthy adults with an accompanying 
degree of asymmetry (inter-limb differences) of at least 2⁰32, 35.  Therefore, a reasonable 
criterion for classification of excessive FPA is a measured FPA of greater than 10±5⁰.   
Lower extremity joint mobility and gait speed. Reported lower extremity joint mobility 
limitations related to slower gait speed include less 1st metatarsophalangeal joint (1st MTPJ) 
extension motion, less ankle dorsiflexion motion, less ankle plantar flexor muscle power and 
peak torque, and decreased hip rotation during walking compared with healthy, age and weight-
matched control subjects27-29,36-39.  In addition, Giacomozzi et al (2008) and Allet et al (2009) 
suggest that decreased gait speed and the associated joint mobility impairments may precede 
the onset or clinical detection of peripheral neuropathy in persons with diabetes mellitus31,38.   
Lower extremity joint mobility and FPA.   Studies from independent groups suggest a 
direct relationship between external FPA and timing and magnitude of medial and lateral PPP in 
adults with DMPN21,32.  However, there is a dearth of evidence identifying specific joint mobility 
limitations associated with excessive external FPA in individuals with DMPN.  Similarly, it is not 
known if changes in FPA characteristics (magnitude and inter-limb asymmetry) progress in 
parallel with the severity of lower extremity impairments associated with DMPN, or if the 
changes in FPA magnitude are modifiable.  Studies from the pediatric orthopedic literature 
provide some evidence for lower extremity joint limitations related to FPA magnitude.  Ho et al 
(2000) and Chang et al (2004) suggest greater ankle dorsiflexion and hip external (lateral) 
rotation are related to increased FPA magnitude in children with and without neuromuscular 
disease40,41 though these impairments have not been identified as contributors to excessive 
FPA in adults with DMPN.  
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1.2. Current neuropathic plantar ulcer (NPU) treatment options.  
 
1.2.a.  Bracing and custom footwear.   
Many treatment options exist for offloading plantar sites to promote wound healing or to 
prevent re-ulceration.  Commonly used pressure offloading strategies include use of custom-
made insoles42, removable cast walking boots, total contact casting, and non-weight bearing 
strategies such as wheelchair usage43.  Though these interventions have been shown to 
successfully reduce forefoot and mid foot PPP in individuals with DMPN and a history of 
NPU43,44, often there are barriers related to cost, patient compliance, and reimbursement43,45.  
Moreover, non-weight bearing offloading techniques potentially contribute to the development 
and progression of mobility limitations reported by individuals with diabetes5.  Though offloading 
strategies may provide the proper healing environment for NPUs, excessive offloading may 
make the tissues vulnerable to re-injury as evidenced by the high rates of re-ulceration (~20-
70%) after successful healing with offloading46,47. 
 
1.2.b. Gait  pattern modification.   
Some research groups have investigated the effects of modified gait patterns on plantar 
pressure distribution in healthy young adults and in adults with DMPN45,48,49.  These modified 
gait patterns were proposed as preventative or healing strategies for people with DMPN at risk 
for first-time or recurrent NPU.  Strategies for those with DMPN include walking slower, reducing 
push off in late stance phase of walking by exaggerating hip flexion48, or walking with a “step-to” 
gait pattern49.  Though these strategies reduce PPP in the forefoot region, reported changes in 
other regions of the plantar surface of the foot are variable.  However, there have been no 
documented results as to whether an excessive external FPA is modifiable in a DM population 
with or without peripheral neuropathy, or the effects of such a modification. 
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1.3. Scope of dissertation 
1.3 a. Unexplored areas of research 
Despite the strong relationship between external FPA and the increased timing and 
magnitude of medial plantar pressure21,32, there are no studies that have investigated the unique 
features of FPA in individuals with DMPN.  Also, to our knowledge, there are no studies that 
have examined the specific joint mobility limitations associated with excessive external FPA in 
individuals with DMPN.  Furthermore, there have been no studies probing whether excessive 
external FPA can be modified in adults with DMPN, thereby potentially creating a strategy for 
early rehabilitative intervention in the lower extremity impairment cascade which often 
culminates in amputation (Figure 1).  Our research seeks to improve our understanding of the 
lower extremity alignment factors that contribute to an excessive external FPA in adults with DM 
with and without peripheral neuropathy, and if those factors are amenable to early intervention 
using modification of walking patterns.    
1.3.b. Expected outcomes 
Based on previous published studies, we hypothesized that limitations in foot, ankle, and 
hip range of motion contribute substantially to excessive external FPA in adults with DMPN27-
29,36-39.  We also hypothesized that after visual and verbal cueing and practice, adults with 
DMPN would be able to intentionally reduce their external FPA, resulting in concomitant 
decreases in PPP particularly in the medial side of the foot.  Figure 1 illustrates the proposed 
relationship between excessive external FPA and the lower extremity impairment cascade of 
excessive medial PPP, medial neuropathic plantar ulceration, and non-traumatic foot 
amputation.  The primary objective of this research was to explore how specific characteristics 
(magnitude and inter-limb asymmetry) of FPA change with disease progression (Aim 1), to 
determine static and dynamic predictors of FPA magnitude (Aim 2), and to examine the effect of 
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a modification of external FPA magnitude on the regional plantar pressure distribution (Aim 3).  
A portion of this project was to investigate the impact of limited hip joint rotation on external FPA 
magnitude in individuals with DMPN (Aim 2). A particularly novel aspect of the project 
represents a considerable expansion of previous literature on hip joint mobility in persons with 
DM, which has only explored hip joint mobility limitations in the sagittal plane with respect to a 
decreased gait speed39.  Given that treatment for joint limitations are within the scope of 
physical therapist practice, intervention(s) targeting lower extremity joint limitations could 
potentially serve as treatment sites to minimize risk for NPU development in DMPN. 
1.4. Specific Aims and Hypotheses 
 
Specific Aim 1.  Determine the characteristics of foot progression angle in groups of 
participants without diabetes mellitus (CON),  with diabetes mellitus without peripheral 
neuropathy (DM only), with diabetes mellitus and peripheral neuropathy WITHOUT a 
history of neuropathic plantar ulcers (DMPN-NPU) with diabetes mellitus and peripheral 
neuropathy WITH a history of neuropathic plantar ulcers (DMPN+ NPU).   
Hypothesis 1.  The primary external FPA characteristic of interest is magnitude, but a 
secondary characteristic of interest is inter-limb asymmetry (i.e., right side versus left side).  We 
hypothesize that individuals with DMPN+NPU will demonstrate an increased external FPA 
magnitude compared with other groups.  
Hypothesis 2. We hypothesize there will be a progressive decrease in inter-limb asymmetry of 
FPA across participant groups with and without DMPN and a prior history of ulceration. 
 
Specific Aim 2.  Determine ability of select lower extremity joint variables to predict FPA 
magnitude.   
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Hypothesis  3.  There will be an inverse relationship between FPA and peak ankle plantar 
flexor power, as well as peak range of motion values for 1st MTPJ extension and ankle joint 
dorsiflexion.  There will be a direct relationship between FPA and hip external rotation range of 
motion.  
Hypothesis 4. Peak hip external rotation range of motion and ankle joint dorsiflexion range of 
motion will account for at least 50% of the variance in external FPA magnitude during the stance 
phase of gait. 
 
Specific Aim 3.  Determine the effect of reducing external FPA on medial peak plantar 
pressure in individuals with DMPN with excessive external FPA.  The primary objective is 
to determine if reducing FPA using instruction, visual and verbal cues and practice trials results 
in concomitant reductions in medial peak plantar pressure in adults with DMPN.   
 Hypothesis 5.  Adults with DMPN who reduce their FPA magnitude to 10⁰ or less will 
demonstrate decreased medial peak plantar pressure compared with pre-intervention values.  
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2.1 Abstract 
In the United States, an estimated 15% of patients with diabetes mellitus and peripheral 
neuropathy (DMPN) have a lifetime risk of neuropathic plantar ulcer (NPU) development, which 
often precedes non-traumatic lower extremity amputation.  Despite evidence of the relationship 
between excessive external foot progression angle (FPA or “toe-out angle”) and plantar 
ulceration risk in individuals with DMPN, specific characteristics of FPA, e.g. magnitude and 
inter-limb asymmetry have not been examined.  The primary purposes of this study were to 
describe the magnitude and inter-limb asymmetry (the difference in FPA between sides).  Forty-
five participants with and without diabetes participated, and were classified into one of four 
groups: 1)  non-diabetic control (CON), 2) diabetes mellitus without peripheral neuropathy 
(DM), 3) diabetes mellitus and peripheral neuropathy without a prior history of a neuropathic 
plantar ulcer (DMPN-NPU), and 4) diabetes mellitus and peripheral neuropathy with a prior 
history of a neuropathic plantar ulcer (DMPN+NPU).   The foot with the higher external FPA 
value was designated the High FPA foot for all groups, while the foot with the lower FPA value 
was designated as the Low FPA foot. The DMPN+NPU group had a greater FPA on the High 
FPA foot than the other groups (DMPN+NPU=-21±5⁰; DMPN-NPU=-13±7⁰; DM=-14±5⁰; CON=-
15±6⁰, p=.03), with no group difference in FPA on the Low FPA foot (DMPN+NPU=-15±9⁰; 
DMPN-NPU=-9±5⁰; DM=-10±5⁰; CON=-8.7±4.8⁰, p=.07).  There was no group difference in 
degree of inter-limb asymmetry (FPA Diff).  These results indicate that it may be useful to 
include measurement of  FPA magnitude as part of a clinical gait assessment  for individuals 
with DMPN with a prior history of ulceration.  
2.2  Introduction 
In the United States, an estimated 15% of patients with diabetes mellitus and peripheral 
neuropathy (DMPN) have a lifetime risk of neuropathic plantar ulcer (NPU) development1.  
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Recent data show more than 65,000 non-traumatic lower extremity amputations in adults with 
DMPN occur annually in the United States, with 84% preceded by the development of a NPU2,3.  
The development and recurrence of NPUs in individuals with DMPN have been linked to the 
protracted duration and magnitude of regional peak plantar pressure (PPP) in areas of the foot 
at risk for skin injury secondary to altered gait characteristics4,5.  Foot progression angle (FPA), 
or “toe-out angle,” is a spatial gait variable defined by the orientation of the longitudinal axis of 
the foot in the transverse plane with respect to the direction of progression during gait6,7.  
Previously established normative values for FPA magnitude range from 5-9⁰ in older and 
younger healthy adults5,8.  Therefore, an accepted criterion for classification of excessive 
external FPA (‘toe-out angle’) is a measured FPA of greater than 10±5⁰.  Chang et al reported a 
direct relationship between an excessive external FPA and the increased duration and 
magnitude of medial PPP in children with neurological pathology9.  Other investigators have 
established FPA as a predictor of elevated medial PPP, a proxy measure of dermal injury risk in 
adults with DMPN with a history of plantar ulceration5,10.  However, findings from this previous 
work have been conducted primarily on the affected limb.  Despite evidence of the direct 
relationship between increased external FPA and PPP in individuals with DMPN, it is unknown if 
FPA magnitude during the stance phase of walking changes in parallel with the severity of lower 
extremity impairments associated with DMPN.     
Inter-limb symmetry of gait patterns is becoming more widely accepted as a measure of 
functional lower extremity motor control and coordination11-13.  Though there is evidence to 
support asymmetry in spatiotemporal gait parameters, muscle performance measures, and joint 
mobility as indicators of gait pathology, there is equally compelling evidence to support 
asymmetry of these variables as a normal feature of gait14.  In a review by Sadeghi et al (2000), 
several investigators have reported asymmetries in step and stride lengths, external FPA, and 
joint kinematics and kinetics in healthy people without lower extremity pathologies14.  
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Researchers have often attributed the presence of any minor  inter-limb asymmetry in gait 
variables to “limb dominance” and to the differential functions of braking and propulsion, or the 
deceleration and acceleration of the body during gait14.  Researchers have reported values of 
inter-limb asymmetry in FPA ranging from 2-4⁰ in healthy young and older adults8,15.  However, 
it is unknown if inter-limb asymmetry in FPA is a feature of normal gait in adults with DMPN 
compared to adults without diabetes.  Furthermore, it is also unclear if there is a similar FPA 
magnitude in both feet of individuals with DMPN at risk for NPU development. Given the 
evidence supporting the link between excessive increased FPA (an FPA of >10±5⁰) and 
increased medial PPP in adults with DMPN, we wanted to characterize FPA across a spectrum 
of older adults with and without DMPN or a prior history of neuropathic plantar ulceration.  
Therefore, the purposes of this study were to describe the magnitude and inter-limb asymmetry 
in adults with and without DMPN and a prior history of plantar ulceration.  We hypothesized 
there would be a progressive increase in FPA magnitude and a progressive decrease in the 
inter-limb asymmetry in FPA across a spectrum of participants with and without DMPN and 
accompanying history of prior ulceration. 
2.3. Methods 
2.3.a. Participants 
Forty-five participants with and without diabetes (21 M, 24 F; age, 60±11 yrs; height, 
1.7±0.1 m; BMI, 36±8) participated, and provided written informed consent as approved by the 
local Institutional Review Board.  Participants were classified into one of four groups: 1) age-
matched  non-diabetic control participants (CON), 2) diabetes mellitus without peripheral 
neuropathy (DM), 3) diabetes mellitus and peripheral neuropathy without a prior history of a 
neuropathic plantar ulcer (DMPN-NPU), and 4) diabetes mellitus and peripheral neuropathy with 
a prior history of a neuropathic plantar ulcer (DMPN+NPU).  The presence or absence of 
18 
 
peripheral neuropathy was assigned based on the presence or absence of protective sensation, 
and ulcer classification was based on any prior history of plantar ulceration. Peripheral 
neuropathy was assessed using a 5.07 (10 gram) Semmes-Weinstein monofilament at seven 
sites on the plantar surface of the foot16.  In addition, we measured vibration perception 
threshold (VPT) using a 120 V bioesthesiometer (Bio-medical Instrument Co., Newbury, OH, 
44065, USA) to assess large fiber peripheral nerve function.  Those who were unable to 
perceive vibration of the bioesthesiometer at threshold of 25 V or greater were classified as 
having peripheral neuropathy.  A VPT >25 V is associated with incidence of foot ulceration in 
individuals with Type 2 diabetes mellitus17. The combination of these tests for protective 
sensation has been shown to increase specificity of risk identification and disease severity 
without diminution in sensitivity17.  Twelve participants were classified as CON, twelve were 
classified as DM, eleven were classified as DMPN-NPU, and ten were classified as 
DMPN+NPU with 8 reporting a history on one foot and 2 participants reporting a history of 
plantar ulcers on both feet (8 unilateral, 2 bilateral). Participants classified as DMPN+NPU did 
not have an open ulcer at the time of testing.  Those identified as non-ambulatory or with lower 
extremity amputations proximal to the digits were excluded from the study. 
2.3.b. Gait Analysis 
2.3.b.1.  Data collection.  Three-dimensional kinematic and kinetic data were collected during 
gait for the pelvis and bilateral lower extremities while participants walked at a self-selected 
speed over a walkway within the capture volume.  Kinematic data were acquired using an 
infrared 8-camera, 200 Hz motion capture system (Vicon MX, Los Angeles, CA, USA), and 
kinetic data were collected using a Bertec K80301 force plate with a resolution of 500 Hz 
(Bertec Corporation, Columbus, OH, USA).   
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2.3.b.2.  Marker placement.  All participants were fitted with 10 mm diameter retro-reflective 
markers affixed directly to the skin or to pre-molded rigid plate in a non-collinear arrangement to 
establish segment coordinate systems for the foot, shank, thigh, pelvis, and trunk.  A 
modification of the “obesity-specific marker set”, described by Lerner et al for the trunk, pelvis, 
and thigh, was used in this study in an effort to account for potential motion artifact secondary to 
adiposity18,19.  Briefly, single markers for the trunk were placed on the body of the sternum, the 
C7 spinous process, right and left acromion processes, and the inferior angle of the scapula.  
Markers on the pelvis included single markers on the right and left posterior superior iliac 
spines, with an accompanying marker cluster placed on the sacrum.  Marker clusters on the 
pelvis have been shown to have greater repeatability and less movement variability during non-
sagittal plane motion of the pelvis in overweight and obese individuals20.  To correct for marker 
displacement secondary to adiposity, digitized markers were created for the anterior superior 
iliac spines and iliac crests with a static digitizing wand (C-Motion, Germantown, MD) using 
procedures described by Lerner et al18,19.  Additional corrections were made using 
measurements of inter-ASIS distance using a skinfold caliper in subject-specific models.  Lerner 
et al reported that use of marker clusters and digitized markers on the thigh and pelvis 
minimized overestimation of lower extremity kinematics and kinetics19.   Single thigh markers 
were placed proximally on the greater trochanter and distally on the medial and lateral femoral 
epicondyles, with a 4-marker cluster for tracking on the distal thigh superior to the lateral 
epicondyle.   
We utilized a marker configuration for the foot and shank described by Carson et al 
(2001) and modified by Hastings et al (2013).  Individual shank markers were placed on the 
fibular head, tibial tuberosity, and malleoli, with a 4-marker cluster placed on the distal shank 
superior to the lateral malleolus22.  To determine FPA magnitude and inter-limb asymmetry, we 
modeled the foot as a single, rigid body segment using three markers in a non-collinear 
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arrangement.  The foot segment was defined by virtual markers created from projected 
midpoints between the lateral and medial malleoli at the proximal end, and between the first and 
fifth metatarsal heads at the distal end.  The hind foot segment was defined by calcaneal marker 
placement on the sustentaculum tali, fibular trochlea, and by three mounted markers on a 
molded plastic plate applied to the posterior calcaneal bisection—a vertical line between the 
sustentaculum tali and the fibular trochlea42.  The forefoot segment was defined distally by a 
marker placed at the midpoint between the second and third metatarsals, and by markers at the 
first and fifth metatarsal heads.  The proximal forefoot was defined by the base of the first and 
fifth metatarsals.  The hallux segment was defined by a plate with three mounted markers 
arranged parallel with the long axis of the proximal phalanx of the great toe22.       
All participants were asked to walk barefoot at a self-selected speed.  All were given at least 1-2 
practice trials prior to recording.  To minimize risks associated with barefoot walking in 
participants in the DMPN-NPU and DMPN+NPU groups, walking distance was truncated to 
include the steps on and at least 10 cm beyond the force plate.   A maximum of five trials in 
which participants were able to contact the force plate without “targeting” were collected.  A 
minimum of three trials were included in the analysis if FPA values were within one standard 
deviation of the within-trial mean for each participant. Stride speed was calculated in the Visual 
3D software as the time for the foot opposite the one contacting the force plate to complete one 
full stride21.  
2.3.c. Data Processing and Analysis.   
2.3.c.1.  Processing.  All marker trajectories and tri-axial force data were processed using a 
fourth-order, low-pass filter in Visual 3D software (C-Motion, Inc, Rockville, MD).  Marker 
trajectories were filtered at 6Hz, and tri-axial force data were filtered at 20Hz.  Inter-segmental 
and global orientation angles were derived using Cardan angle sequences, and parallel 
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alignment of the segmental axes represent neutral position22.  FPA was calculated as the 
magnitude of transverse plane rotation of the foot segment around the local superior-inferior 
axis at mid stance (i.e., 50% of the stance phase)23.    Kinematic convention for all FPA 
measurements was to designate external FPA (toe-out angle) as negative and internal FPA 
(toe-in angle) as positive.       
2.3.c.2.  Statistical analyses.  Prior to all analyses, we conducted the Shapiro-Wilk test of 
normality to verify that continuous data for both FPA and FPA Diff was normally distributed.  
Each foot for all participants was classified as High FPA or Low FPA based on the FPA 
magnitude.  The foot with the greater FPA was classified as High FPA for all groups, while the 
foot with the lesser FPA was classified Low FPA.   
Based on previous work investigating asymmetry in lower extremity variables during 
gait24,25 we initially performed a two-way analysis of variance (Group [4 levels] X Side [2 levels]) 
to determine the main and interaction effects of group and side.  We then quantified the degree 
of inter-limb asymmetry (FPA Diff) as the absolute value of the difference in FPA magnitude 
between the High FPA and Low FPA feet (|High-Low|), and performed a univariate analysis of 
variance to determine group differences..  Based on previous work8,15, the criterion for having a 
clinically meaningful measure of FPA Diff have reported degrees of asymmetry was 4⁰.  
Statistical analyses were performed using IBM SPSS Statistics software, version 21.0 (SPSS 
Inc, Chicago, IL, USA).  Post-hoc analyses for main and interaction effects were conducted 
using a Bonferroni correction, with statistical significance for all analyses set at p<.05. 
2.4. Results 
2.4.a. Participant Characteristics  
The mean (SD) age for all participants (N=45) was 60 (10) years (range: 44-85 years). 
There were no group differences in age, height or body mass index (BMI)(Table 2.1). The 
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DMPN+NPU group had diabetes for a longer duration and had greater loss of vibration 
perception than the DM group (Disease duration in years): DM=8±5, DMPN-NPU=11±9, 
DMPN+NPU= 24±8; p<.01).  The DMPN-NPU and DMPN+NPU groups had a significantly 
greater vibration perception threshold than the DM and CON groups (DMPN+NPU=34 V; 
DMPN-NPU=37 V, p<.01).  There were no between-group differences in stride speed (p=.80) 
(Table 2.1). 
2.4.b. FPA magnitude 
The DMPN+NPU group had a greater FPA magnitude on the High FPA foot 
(DMPN+NPU=-21±5⁰; DMPN-NPU=-13±7⁰; DM=-14±5⁰; CON=-15±6⁰, p=.03), with a trend 
toward a greater FPA magnitude in the Low FPA foot compared with the other groups 
(DMPN+NPU=-15±6⁰; DMPN-NPU=-9±7⁰; DM=-10±5⁰; CON=-9±5⁰, P=.07).  Posthoc testing 
showed a greater FPA for the High FPA foot in the DMPN+NPU group compared to the DMPN-
NPU group (p=.03).  Values for the High and Low FPA feet for each group are presented in 
Table 2.2.  Statistical analysis revealed the presence of outlier values for FPA on both feet in 
the control group (CON=-32⁰) and for the DMPN-NPU group (DMPN-NPU=1⁰).   Values for FPA 
on either foot were considered outliers if they were two or more standard deviations from the 
group mean FPA value.  Results from analysis with outliers excluded revealed enhanced group 
differences in the High FPA foot (DMPN+NPU-21±5⁰; DMPN-NPU=-15±5⁰; DM=-14±5⁰; CON=-
13±3⁰, p=.01) and Low FPA foot (DMPN+NPU-15±9⁰; DMPN-NPU=-9±4⁰; DM=-10±5⁰; CON=-
8±3⁰, p=.03).  Values for both feet for each group with outliers excluded are shown in Table 2.3.  
Time series motion graphs of FPA excursion during the stance phase of gait is illustrated in 
Figure 2.1.    
2.4.c. FPA asymmetry 
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There was a main effect of side, with the High FPA foot having a greater FPA magnitude than 
the Low FPA foot (p<.01).  There was no interaction effect of group x side (p=.76), which was 
confirmed by the lack of FPA Diff between the groups (DMPN+NPU=6±6⁰; DMPN-NPU=5±4⁰; 
DM=3±6⁰; CON=6±4⁰, p=.36).   When outliers were removed from the analysis, there were no 
group differences in FPA Diff.  FPA Diff for all groups is shown in Table 2.2. 
2.5 Discussion 
This is the first investigation to determine the characteristics of FPA in individuals with 
and without diabetes mellitus.  One of the key findings from this investigation is that external 
FPA on the High FPA and Low FPA feet of the DMPN+NPU were greater in magnitude than the 
other participant groups.  Additionally, there were no between-group differences in inter-limb 
asymmetry (FPA Diff). 
The FPA values for the High FPA foot of all participant groups were greater than 10⁰, 
and would therefore be classified as excessive compared to young adults15.  Findings of greater 
FPA values in both feet of participants with DMPN with a prior history of ulceration compared 
with adults without DM is consistent with previous findings from other research groups5,10. 
Hastings et al reported an FPA of greater than 10⁰ in both feet of individuals with DMPN with a 
history of ulceration5.  This group also stated that FPA magnitude for both feet explained 35-
45% of the variance in the duration of medial load in adults with DMPN with a prior history of 
neuropathic plantar ulceration5.   In addition, Mueller et al reported that FPA predicted up to 
15% of the variance in medial and lateral forefoot peak plantar pressure on the involved foot of 
individuals with DMPN having a prior history of neuropathic plantar ulcers10.  These findings 
suggest that an excessive FPA in the presence of peripheral neuropathy potentially exposes 
individuals with DMPN with a prior history of ulceration to elevated regional peak plantar 
pressure sustained for longer duration on the medial side of the foot and subsequently, to an 
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elevated risk for NPU development.  Therefore, it may be clinically useful to observe and 
measure FPA in one or both feet of adults with DMPN with a prior history of ulceration as part of 
an assessment of risk for elevated regional stresses and loads that often lead to the 
development of new NPUs or recurrent NPUs in the same location on the plantar surface of the 
foot.  Future studies could identify predictors of FPA magnitude in a cohort of older adults with 
and without DMPN.  
In the present study, we observed no group differences in FPA inter-limb asymmetry.  
These results may indicate that FPA asymmetry in a cohort of adults with and without DMPN is 
not disease-specific, and may be a common spatial characteristic of gait in adults 50 years or 
older.  Several investigators have reported inter-limb differences in movement patterns, force 
output, and spatiotemporal parameters as an indicator of disease progression and severity, 
though smaller degrees of asymmetry were  also reported in groups without pathology 14,25,29-31.  
However, there is also evidence to support inter-limb asymmetry in joint alignment and function 
as characteristics of normal gait.  Sadeghi et al suggest that the cumulative effect of 
asymmetries in individual joint function (‘local asymmetry’) possibly culminate into symmetric 
performance of the lower extremities during gait (‘global symmetry’)24.  Also, Riskowski and 
colleagues reported that in population-level study of older adults, greater degrees of asymmetry 
in foot alignment were associated with faster walking speeds and more optimal foot function11.  
These findings suggest that inter-limb asymmetry of FPA may contribute to optimal gait 
performance.  Additionally, measurement of the difference in FPA between feet may not be 
clinically relevant for the assessment of risk for elevated regional stresses and loads, and 
subsequently, the development or recurrence of NPUs in adults with and with DMPN with a prior 
history of ulceration. 
 There are limitations associated with this study.  One limitation is the small sample size 
of the individual groups. Additionally, our selection criteria for study participation were primarily 
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based on disease status, and not on FPA magnitude or inter-limb asymmetry.   Refinement of 
our selection criteria plus inclusion of additional participants may have potentially resulted in 
more robust differences in FPA magnitude.  Finally, we selected one of many possible methods 
of quantifying asymmetry which we believed was appropriate given the purpose of the study.  
The variation in determining inter-limb asymmetry for spatiotemporal gait variables may be 
challenging to compare across studies.  
2.6. Conclusion 
Results from this investigation highlight the differences in FPA magnitude across a 
cohort of adults with and without DMPN and a prior history of ulceration.  These findings 
suggest that an excessive FPA in the presence of peripheral neuropathy potentially exposes 
individuals with DMPN with a prior history of ulceration to elevated regional stresses and loads 
on the plantar surface of the foot.  Therefore, it may be clinically useful to observe and measure 
FPA in one or both feet of adults with DMPN with a prior history of ulceration as part of an 
assessment of risk for elevated regional stresses and loads that often lead to the development 
of new NPUs or recurrent NPUs in the same location on the plantar surface of the foot.  
Findings from this study also suggest that FPA inter-limb asymmetry is not disease-specific, and 
may be a common spatial characteristic of walking patterns in adults 50 years or older.   
 
 
 
 
 
26 
 
REFRENCES 
1. Owings TM, Apelqvist J, Stenström A, Becker M, Bus SA, Kalpen JS et al. Plantar 
pressures in diabetic patients with foot ulcers which have remained healed. Diabet Med 
2009; 26:1141-1146 
 
2. Centers for Disease Control and Prevention.  National Diabetes Fact Sheet, 2011. 
http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.  Published 2011. Accessed 
January 23, 2014 
 
3. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for 
prevention. Diabetes Care 1990; 13(5):513-521 
 
4. Rao S, Saltzman C, Yack HJ. Segmental foot mobility in individuals with and without 
diabetes and peripheral neuropathy. Clin Biomech 2007; 22(4): 464-471 
 
5. Hastings MK, Gelber JR, Isaac EJ, Bohnert KL, Strube MJ, Sinacore DR. Foot 
progression angle and medial loading in individuals with diabetes mellitus, peripheral 
neuropathy, and a foot ulcer. Gait Posture 2010; 32:237-241 
 
6. Holden JP, Cavanaugh PR, Williams KR, Bednarski KN. Foot angles during walking and 
running.    1985 International Series on Biomechanics: Biomechanics IX-A. Human 
Kinetics Publishers, Champaign, IL 
 
7. Lai YC, Lin HS, Pan HF, Chang WN, Hsu CJ, Renn JH.  Impact of foot progression 
angle on the distribution of plantar pressure in normal children. Clin Biomech 2014; 
29(2):196-200 
 
8. Menz GH, Latt MD, Tiedermann A, Mun San Kwan M, Lord SR. Reliability of the 
GAITRite walkway system for the quantification of temporo-spatial parameters of gait in 
young and older people. Gait Posture 2004; 20(1): 20-25 
 
9. Chang WN, Tsirikos AI, Miller F, Schyler J, Glutting J. Impact of changing foot 
progression angle on foot pressure measurement in children with neuromuscular 
disease. Gait Posture 2004; 20(1): 14-19 
 
10. Mueller MJ, Hastings MK, Commean PK, Smith KE, Pilgram,TK, Robertson D et al. 
Forefoot structural predictors of plantar pressures during walking in people with diabetes 
and peripheral neuropathy. J Biomech 2003; 36(7):1009-1017 
 
11. Riskowkski JL, Hagedorn TJ, Dufour AB, Hannan MT. Functional foot symmetry and its 
relation to lower extremity physical performance in older adults: the Framingham Foot 
Study. J Biomech 2012; 45(10):1796-1802 
 
12. Kodesh E, Kafri M, Dar G Dickstein R. Walking speed, unilateral leg loading, and step 
symmetry in young adults. Gait Posture 2012; 35(1):66-69 
 
13. Patterson KK, Nadkarni NK, Black SE, McIlroy WE. Gait symmetry and velocity differ in 
their relationship to age.  Gait Posture 2012; 35(4): 590-594 
 
27 
 
14. Sadeghi H, Allard P, Prince F, Labelle H. Symmetry and limb dominance in able-bodied 
gait: a review. Gait Posture 2000; 12(1): 34-45 
 
15. Boenig DD. Evaluation of a clinical method of gait analysis. Phys Ther 57(7):795-798 
 
16. Diamond JE, Mueller MJ, Delitto A, Sinacore DR. Reliability of diabetic foot evaluation. 
Phys Ther 1989; 69(10):797-802 
 
17. Kästenbauer T, Sauseng S, Brath H, Abrahamian H, Irsigler K. The value of the Rydel-
Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a 
neurothesiometer. Diabet Med 2004; 21(6): 563-567 
 
18. Lerner, ZF, Board, WJ, Browning, RC. Effects of obesity on lower extremity muscle 
function during walking at two speeds.  Gait Posture 2013; pii: S0966-6362(13)00715-7.  
doi:10.1016/j.gaitpost.2013.12.020 
 
19. Lerner ZF, Board WJ, Browning RC. Effects of an obesity-specific marker set on 
estimated muscle and joint forces in walking. Med Sci Sports Exerc 2014;  PMID: 
24518193 
 
20. Borhani M, McGregor AH, Bull AM. An alternative technical marker set for the pelvis is 
more repeatable than the standard pelvic marker set. Gait Posture 2013; 38(4):1032-
1037 
 
21. Carson MC, Harrington ME, Thompson N, O’Connor JJ, Theologis TN.  Kinematic 
analysis of a multi-segment foot model for research and clinical applications: a 
repeatability analysis. J Biomech 2001; 34(10): 1299-1307 
 
22. Hasting MK, Sinacore DR, Woodburn J, Paxton ES, Klein SE, Bohnert KL et al. 
Kinematics and kinetics after the Bridle procedure for treatment of traumatic foot drop.  
Clin Biomech 2013; 28(5): 555-561 
 
23. Raspovic, A. Gait characteristics of people with diabetes-related peripheral neuropathy, 
with and without a history of ulceration. Gait Posture 2013; 38(4):723-728 
 
24. Sadeghi, H. Local or global asymmetry in gait of people without impairments.  Gait 
Posture 2003; 17(3): 197-204 
 
25. Mills, K, Hettinga, BA, Pohl, MB, Ferber, R. Between-limb kinematic asymmetry during 
gait in unilateral and bilateral mild to moderate knee osteoarthritis.  Arch Phys Med 
Rehabil 2013; 94(11): 2241-2247 
 
26. Mueller MJ, Zou D, and Lott DJ. “Pressure gradient” as an indicator of plantar skin injury. 
Diabetes Care 2005; 28(12): 2908-2912 
 
27. Rao S, Saltzman C, Yack HJ. Ankle ROM and stiffness measured at rest and during gait 
in individuals with and without diabetic sensory neuropathy. Gait Posture 2006; 24(3): 
295-301 
  
28 
 
28. Giacomozzi C, D’Ambriogi E, Cesinaro S, Macellari V, Uccioli L. Muscle performance 
and ankle joint mobility in long-term patients with diabetes. BMC Musculoskelet Disord 
2008; 9:99 
 
29. Perry MC, Carville SF, Smith CH, Rutherford OM, Newham DJ. Strength, power output 
and symmetry of leg muscles: the effect of age and history of falling. Eur J Appl Physiol 
2007; 100(5): 527-533 
 
30. Briem K, Snyder-Mackler L. Proximal gait adaptations in medial knee OA. J Orthop Res 
2009; 27(1): 78-83 
 
31. Laroche DP, Cook SB, Mackala K. Strength asymmetry increases gait asymmetry and 
variability in older women. Med Sci Sports Exerc 2012; 44(11): 2172-2181 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
29 
 
 
CON 
(N=12) 
 
DM 
(N=12) 
 
DMPN-NPU 
(N=11) 
 
DMPN+NPU 
(N=10) 
 
p 
Age (years) 60 (12) 58 (9) 63 (11) 58 (11) .80 
Height (meters) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) .79 
Sex (M:F) 7:5 5:7 4:7 5:5 .95 
BMI (kg/m2) 33 (5)† 34 (8)#  39 (9) 41 (9) .08 
Disease duration (years) N/A 8 (5)# 11 (9)§ 24 (8) <.01 
Great Toe VPT (Volts) 20 (9) 15 (6) 37 (11) 34 (17) <.01 
Walking Speed (m/s) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) .80 
Side of greater FPA (R:L) 11R:1L 9R:3L 9R:3L 6R:4L -- 
 
Table 2.1.  Participant characteristics.  Values are expressed in mean (SD).  VPT: vibration 
perception threshold (Volts).  Side with greater FPA magnitude (R:L): Number of right feet (R) or 
left feet (L).  †,#,§ :significance values for between-group differences in participant 
characteristics. †: CON versus DMPN-NPU and DMPN+NPU; #: DM versus DMPN-NPU and 
DMPN+NPU; §:DMPN-NPU versus DMPN+NPU 
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 CON 
(N=12) 
 
DM 
(N=12) 
 
DMPN-NPU 
(N=11) 
 
DMPN+NPU 
(N=10) 
p 
 High Low High Low High Low High Low  
FPA (deg) -15 (6)* -9 (5)* -14 (5)* -10 (5)* -13 (7)#* -9 (5)* -21 (5)* -15 (9)* .03 
 
FPA Diff  
 
6(4) 
 
3(7) 
 
5(4) 
 
6(6) 
 
.36 
 
Table 2.2.  Foot progression angle (FPA) magnitude for each foot for all participants.  Values 
are expressed in degrees, mean (SD).  High: foot with the higher FPA magnitude (High FPA). 
Low: foot with the lower FPA magnitude (Low FPA). FPA Diff: the absolute difference in FPA 
magnitude between the High FPA and Low FPA feet (|High-Low|). #: Between-group differences 
in FPA magnitude of the High foot.  DMPN-NPU versus DMPN+NPU.  *: Paired mean 
differences in FPA for all groups, p<.01.  
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CON 
(N=12) 
 
DM 
(N=12) 
 
DMPN-NPU 
(N=11) 
 
DMPN+NPU 
(N=10) 
 
p 
 High Low High Low High Low High Low  
FPA (deg) -13 (3)†* -8 (3)* -14 (5)#* -10 (5)* -15 (5)* -9 (4)* -21 (5)#* -15 (2)* <.01 
 
FPA Diff 
(|High-Low|) 
 
6(4) 
 
3(6) 
 
5(4) 
 
6(6) 
 
.40 
Table 2.3.  Foot progression angle (FPA) magnitude for each foot with outliers excluded from 
the analysis.  Values are expressed in degrees, mean (SD).  High:  foot with the higher FPA 
magnitude (High FPA). Low: foot with the lower FPA magnitude (Low FPA). FPA Diff: the 
absolute difference in FPA magnitude between the High and Low feet.  †,#,§ : Between-group 
differences in FPA magnitude of the High foot. †:  CON versus DMPN+NPU; #:  DM versus 
DMPU+NPU; §:  DMPN-NPU versus DMPN+NPU. *: Paired mean differences in FPA for all 
participant groups, p<.01  
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Figure 2.1. Time series motion graph of foot progression angle (FPA) during the stance of gait. 
The blue line and shaded region represents the mean±1 standard deviation of the motion for the 
CON group.  Boxed regions represent values used in the analysis. Figure legend. CON: non-
diabetic control participants; DM: diabetes mellitus without peripheral neuropathy group; DMPN-
NPU: diabetes mellitus with peripheral neuropathy without a previous neuropathic plantar ulcer; 
DMPN+NPU: diabetes mellitus with peripheral neuropathy with a previous neuropathic plantar 
ulcer 
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3.1 Abstract 
The development and recurrence of neuropathic plantar ulcers (NPU) are a significant 
health and economic burden worldwide.  In the United States, an estimated 12 to 25% of adults 
with diabetes mellitus and peripheral neuropathy (DMPN) have a lifetime risk of NPU 
development.  Foot progression angle (FPA or “toe-out angle”) has been identified as a 
predictor of elevated medial and lateral plantar loading in individuals with DMPN.  Despite FPA 
being reported as a predictor of regional plantar stress in individuals with DMPN, there have 
been no identified static or dynamic predictors of FPA magnitude.  The primary purpose of this 
study was to determine static (goniometric) and dynamic (gait kinematics and kinetics) 
predictors of FPA magnitude in adults with DMPN.  In a hierarchical multiple regression analysis 
of static predictor variables, total hip excursion, ankle dorsiflexion range of motion, and resting 
calcaneal stance position (RSCP) accounted for 29% of FPA variance.  However, the unique 
contribution of these variables was not statistically significant (p>.05).  In a hierarchical multiple 
regression analysis of the dynamic predictor variables, the overall contribution of all dynamic 
predictor variables to FPA was 48%.  Thigh and shank external (lateral) rotation accounted for 
37% of the variance in FPA (p<.01).  These findings suggest that external rotation of proximal 
segments during gait better predict FPA than static (goniometric) measures of limited joint 
mobility and joint position at the hip, ankle, and subtalar joints in individuals with DMPN.  
Identification of dynamic predictors of FPA could inform areas for clinical assessment and 
targets for treatment of lower extremity impairments earlier in the lower extremity impairment 
cascade to minimize risk of elevated plantar stresses and loads that often lead to NPU 
development.    
 
3.2 Introduction 
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In the United States, an estimated 15% of patients with diabetes mellitus and peripheral 
neuropathy (DMPN) have a lifetime risk of neuropathic plantar ulcer (NPU) development1,2.  
Recent statistics show more than 65,000 non-traumatic lower extremity amputations in adults 
with DMPN occur annually in the United States, with 84% preceded by the development of a 
NPU3,4. Elevated regional peak plantar pressure is an established index of risk dermal injury in 
adults with DMPN6,7, and is thought to initiate a lower extremity impairment cascade of NPU 
development and subsequent non-traumatic lower extremity amputation in individuals with 
DMPN.   
Selected measures of gait performance and of foot and ankle function during gait have 
been identified as dynamic (gait kinematic or kinetic) predictors of elevated regional stresses 
and loads in adults with DMPN with and without a history of ulcer 6,8,9.  Adults with DMPN often 
exhibit the following spatiotemporal gait abnormalities:  1) slower gait speed, 2) larger external 
foot progression angle (FPA) or ‘toe-out angle’, and 3) prolonged stance time compared with 
healthy control participants10-14.   Several investigators have reported specific lower extremity 
kinematic and kinetic impairments associated with spatiotemporal gait abnormalities in adults 
with DMPN.  Slower gait speed is associated with decreases in 1st metatarsophalangeal joint 
(MTPJ) extension motion, ankle dorsiflexion motion, ankle plantar flexor muscle power, and hip 
rotation motion in adults with DMPN compared with healthy control subjects12,15-18.   Foot 
progression angle is a spatial gait variable defined by the orientation of the longitudinal axis of 
the foot in the transverse plane with respect to the direction of gait progression19,20.  Studies 
from independent groups report external FPA as a dynamic predictor of elevated regional 
plantar stresses and loading in individuals with DMPN6,8.  However, there is limited available 
evidence identifying dynamic predictors of FPA.  In studies from pediatric orthopedic literature, 
Ho et al suggest that the degree of ankle dorsiflexion motion during gait is related to FPA 
magnitude in healthy children21.  Lee et al report that inter-segmental external (lateral) rotation 
of the pelvis (r=-49, p<.01) and knee (shank to thigh) during gait (r=.38, p=.03) is significantly 
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correlated with FPA, whereas hip (thigh to pelvis) is not significantly correlated with FPA in 
children with cerebral palsy (r=.33, p=.06)22.  Yet it is unknown if these are dynamic predictors of 
FPA in individuals with DMPN with and without a history of prior NPU.   
Limited joint mobility of the foot and ankle is often measured during clinical assessment 
of lower extremity function.  Selected goniometric measures of alignment and limited joint 
mobility of the foot and ankle have been reported as static predictors of elevated regional peak 
plantar pressure in adults with DMPN with and without a history of ulcer23,24.  Zimny et al 
reported that decreased ankle dorsiflexion and 1st MTPJ extension motions were inversely 
correlated with forefoot plantar loads in participants with DMPN without a history of a prior 
NPU23.  Turner and associates also noted a correlation between 1st MTPJ extension motion and 
peak plantar pressure24.  Despite the reported impairments in motion and alignment of the 1st 
MTPJ and ankle joints as static predictors of elevated plantar stresses and loads, it is unclear if 
these impairments predict FPA.    
Foot progression angle and selected measures of joint alignment and mobility in the foot 
and ankle are static and dynamic predictors of elevated regional plantar stresses and loads in 
adults with DMPN.  However, there are no reported static or dynamic predictors of external FPA 
in individuals with DMPN despite FPA being an established predictor of regional plantar 
stresses and loads.  Therefore, the purposes of this study were to: 1) determine static and 
dynamic predictors of FPA in individuals with and without DMPN, and 2) determine the 
between-group differences in select lower extremity static and dynamic measures of foot, ankle, 
and hip rotation.  We hypothesized that select static and dynamic predictor variables would 
explain a significant portion of the variance in FPA.  Additionally, we hypothesized a hierarchical 
model of dynamic predictor variables would explain a greater portion of FPA variance compared 
with a hierarchical regression model of static predictor variables.  
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3.3 Methods  
3.3. a. Participants 
Forty-five participants with and without diabetes (21 M, 24 F; age, 60±11 yrs; height, 
1.7±0.1 m; BMI, 36±8) participated, and provided written informed consent as approved by the 
local Institutional Review Board. Participants were classified into one of four groups: 1) age-
matched  control (CON), 2) diabetes mellitus without peripheral neuropathy (DM), 3) diabetes 
mellitus and peripheral neuropathy without a prior history of a neuropathic plantar ulcer (DMPN-
NPU), and 4) diabetes mellitus and peripheral neuropathy with a prior history of a neuropathic 
plantar ulcer (DMPN+NPU) .  The presence or absence of peripheral neuropathy was assigned 
based on the presence or absence of protective sensation, and ulcer classification was based 
on any prior history of plantar ulceration. Peripheral neuropathy was assessed using a 5.07 (10 
gram) Semmes-Weinstein monofilament at seven sites on the plantar surface of the foot25.  In 
addition, we measured vibration perception threshold (VPT) using a 120 V bioesthesiometer 
(Bio-medical Instrument Co., Newbury, OH, 44065, USA) to assess large fiber peripheral nerve 
function.  Those who were unable to perceive vibration of the bioesthesiometer at threshold of 
25 V or greater were classified as having peripheral neuropathy.  A VPT >25 V is associated 
with incidence of foot ulceration in individuals with Type 2 diabetes mellitus26. The combination 
of these tests for protective sensation has been shown to increase specificity of risk 
identification and disease severity without diminution in sensitivity26.  Twelve participants were 
classified as CON, twelve were classified as DM, eleven were classified as DMPN-NPU, and 
ten were classified as DMPN+NPU with 8 reporting having had a prior ulcer on one foot  and 2 
participants reporting having had a prior  ulcer on both feet (8 unilateral, 2 bilateral). Participants 
classified as DMPN+NPU did not have an open ulcer at the time of testing.        
3.3.b. Static predictor measurement   
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3.3.b.1.  Data collection.  Static predictors in this investigation were operationally 
defined as goniometric measures of motion and position of select lower extremity joints.  Hip 
(coxafemoral) joint internal (medial) and external (lateral) rotation were measured using a 
bubble inclinometer (Medical Research Ltd, Leeds LS124JF, United Kingdom) with a precision 
of 1⁰ using the methods described by Elllison et al (1990)27.  Hip rotation was selected for 
measurement because of the reported kinematic link between hip rotation and FPA magnitude 
in children28,.  The reported intra-rater reliability for hip internal and external rotation 
measurement using the procedures outlined by Ellison et al ranges from .95-.99 in both 
directions in subjects with and without low back pain dysfunction27.  Total hip rotation range of 
motion is the sum of hip internal (medial) rotation and hip external (lateral) rotation. 
Ankle (talocrural) joint dorsiflexion excursion was measured in two positions using a 
standard goniometer with a precision of 2⁰, while ankle plantar flexion was measured in the 
prone position.  Ankle joint dorsiflexion excursion was measured with each participant lying 
prone using previously described procedures25.  Measurement of ankle joint dorsiflexion 
excursion in non-weight bearing is performed with the subtalar joint held in palpated neutral 
alignment while the calcaneus moves into dorsiflexion25.  Ankle joint dorsiflexion excursion was 
also measured in the standing position with the axis of the goniometer aligned with the lateral 
malleolus, the moveable arm aligned with the axis of the lateral malleolus and fibular head, and 
the stationary arm aligned parallel to the floor.   Measurement of ankle joint dorsiflexion in 
standing allows for dorsiflexion motion without manual fixation of the talus.    Limited ankle 
dorsiflexion motion is reported to contribute to elevated regional plantar pressures and localized 
skin breakdown on the plantar surface of the forefoot6,29.  The reported intra-rater reliability for 
ankle joint ROM measurement using the procedures outlined by Diamond et al (1989) ranges 
from .89-.9625. 
39 
 
First metatarsophalangeal joint (1st MTPJ) extension was measured in sitting with a 
standard goniometer using procedures described by Menz et al30.  First metatarsophalangeal 
joint (1st MTPJ) range of motion was also measured in the standing position with the axis of the 
goniometer aligned over the medial aspect of the 1st metatarsal head, the moveable arm aligned 
with the first ray, and the stationary arm aligned with the floor.   
Calcaneal position in the frontal plane was measured with the participant in the weight 
bearing and non-weight bearing positions using a modified procedure described by Picciano et 
al (1993)31. For the non-weight bearing measurement of calcaneal frontal plane motion, 
participants were in the prone position with the knee of the foot being measured in the extended 
position.  Using a water-soluble marker, a line of bisection of the lower one-third of the leg was 
drawn31.  In a similar fashion, a line was drawn between the lateral and medial malleoli 
representing a bisection of the calcaneus31.  Then, the angle between the lines of bisection on 
the lower leg and calcaneus were measured using a standard 2⁰ goniometer31.  The axis of the 
goniometer was aligned a midpoint between the malleoli, and the stationary and moveable arms 
aligned with the line of bisection for the lower leg and calcaneus, respectively31.  We also 
measured resting calcaneal stance position (RSCP), a weight bearing measurement of 
calcaneal position using modified measurement procedures described by Picciano et al31.  With 
participants in standing, RCSP values represent the alignment of the calcaneus determined as 
the angle formed between the lines of the bisection of the posterior calcaneus and the floor 
using a standard 2⁰ goniometer31.     
3.3.c. Dynamic predictor measurement 
3.3.c.1.  Data collection.  Dynamic predictors in this investigation were operationally defined as 
lower extremity segmental and inter-segmental positions and orientations at select points during 
the stance phase of gait.  Three-dimensional kinematic and kinetic data were collected during 
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gait for the trunk, pelvis, and bilateral lower extremities while participants walked at a self-
selected speed over a 4 m distance.  Kinematic data were acquired using an infrared 8-camera, 
200 Hz motion capture system (Vicon MX, Los Angeles, CA, USA), and kinetic data were 
collected using a Bertec K80301 force plate with a resolution of 500 Hz (Bertec Corporation, 
Columbus, OH, USA).   
3.3.c.2.  Marker placement.  All participants were fitted with 10 mm diameter retro-reflective 
markers affixed directly to the skin or to pre-molded rigid plate in a non-collinear arrangement to 
establish segment coordinate systems for the foot, shank, thigh, pelvis, and trunk.  A 
modification of the “obesity-specific marker set”, described by Lerner et al for the trunk, pelvis, 
and thigh, was used in this study in an effort to account for potential motion artifact secondary to 
central adiposity32,33.  Briefly, single markers for the trunk were placed on the body of the 
sternum, the C7 cervical spinous process, right and left acromion processes, and the inferior 
angle of the right scapula.  Markers on the pelvis included single markers on the right and left 
posterior superior iliac spines, with an accompanying marker cluster placed on the sacrum.  
Marker clusters on the pelvis have been shown to have greater repeatability and less movement 
variability during non-sagittal plane motion of the pelvis in overweight and obese individuals34.  
To correct for marker displacement secondary to central adiposity, digitized markers were 
created for the anterior superior iliac spines and iliac crests with a static digitizing wand (C-
Motion, Germantown, MD) using procedures described by Lerner et al32,33.  Additional 
corrections were made using measurements of inter-ASIS distance using skinfold caliper in 
subject-specific models.  Lerner et al reported that use of marker clusters and digitized markers 
on the thigh and pelvis minimized overestimation of lower extremity kinematics and kinetics32.   
Single thigh markers were placed proximally on the greater trochanter and distally on the medial 
and lateral femoral epicondyles, with a 4-marker cluster for tracking on the distal thigh superior 
to the lateral epicondyle.   
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We utilized a marker configuration for the foot and shank described by Carson et al35 
and modified by Hastings et al36, which included a single, rigid body foot segment36.  Individual 
shank markers were placed on the fibular head, tibial tuberosity, and malleoli, with a 4-marker 
cluster placed on the distal shank superior to the lateral malleolus.  The hind foot segment was 
defined by calcaneal marker placement on the sustentaculum tali, fibular trochlea, and by three 
mounted markers on a molded plastic plate applied to the posterior calcaneal bisection—a 
vertical line between the sustentaculum tali and the fibular trochlea36.  The forefoot segment 
was defined distally by a marker placed at the midpoint between the second and third 
metatarsals, and by markers at the first and fifth metatarsal heads.  The proximal forefoot was 
defined by the base of the first and fifth metatarsals.  The hallux segment was defined by a plate 
with three mounted markers arranged parallel with the long axis of the proximal phalanx of the 
great toe36.      
Participants were asked to walk barefoot at a self-selected speed.  All were given at 
least 1-2 practice trials prior to recording.  To minimize risks associated with barefoot walking in 
participants in the DMPN-NPU and DMPN+NPU groups, walking distance was truncated to 
include the steps on and at least 10 cm beyond the force plate.   A minimum of five trials in 
which participants were able to contact the force plate without “targeting” was collected.  A 
minimum of three trials were included in the analysis if values were within one standard 
deviation of the within-trial mean for each participant. Walking speed was calculated as stride 
length time of the foot contralateral to the limb contacting the force plate36.  
3.3.d. Data Processing and Statistical Analysis.  
3.3.d.1.  Kinematic and kinetic variables.  All marker trajectories and tri-axial force data were 
processed using a fourth-order, low-pass filter in Visual 3D software (C-Motion, Inc, Rockville, 
MD).  Marker trajectories were filtered at 6Hz, and tri-axial force data were filtered at 20Hz.  
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Inter-segmental and global orientation angles were derived using Cardan angle sequences, and 
parallel alignment of the segmental axes represent neutral position36. Foot progression angle 
was the value of transverse plane rotation of the foot segment around the local superior-inferior 
axis at the mid stance of the gait cycle (i.e., 50% of the stance phase of walking)37.     
3.3.d.2.  Group comparisons.  Prior to all analyses, we conducted the Shapiro-Wilk test of 
normality to verify that continuous data for both FPA and all static and dynamic predictor 
variables were normally distributed38.  Each foot for all participants was classified as either a 
High FPA or Low FPA based on the FPA magnitude.  The foot with the greater FPA was 
classified as High FPA for all groups, while the foot with the lesser FPA was classified Low FPA.   
All static and dynamic predictor variables for the High FPA foot were analyzed using a 
multivariate analysis of variance (MANOVA) to determine group differences.  This analysis was 
performed to determine if group assignment should be included into a hierarchical multiple 
regression analyses for both static and dynamic predictor variables.  Post-hoc analyses were 
conducted using a Bonferroni correction, with statistical significance for all analyses set at 
p<.05.  Statistical analyses were performed using IBM SPSS Statistics software, version 21.0 
(SPSS Inc, Chicago, IL, USA).   
3.3.d.3.  Hierarchical multiple regression analyses.  The following hierarchical multiple 
regression analyses were conducted, and are summarized below.   Variables were considered 
predictors of FPA in the multiple regression analyses if they met the following a priori criteria: 1) 
the predictor variable had a unique contribution to FPA variance of at least 5%, and 2) the 
statistical significance of the change in the overall F value for the coefficients was less than 
.056,39.   
  Hierarchical multiple regression model of static predictors.  Because we had no a 
priori hypothesis of specific static predictors of FPA, we analyzed the relationship between all 
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static predictor variables and FPA on the High FPA foot using Pearson product moment 
correlation coefficient (r)6,38  and coefficients of determination (R2).  Three of fourteen candidate 
static predictor variables plus group predictor variables were selected for inclusion into a 
hierarchical multiple regression analysis based on preliminary bivariate correlation and 
coefficient of determination analyses.  Static predictor variables entered into the model were 
total hip rotation range of motion, ankle joint dorsiflexion range of motion in non-weight bearing, 
and RSCP.  Order for model entry for the static predictor variables was based on the proximal to 
distal location of the joint in the lower extremity. 
Hierarchical multiple regression model of dynamic predictors.  Two hierarchical 
multiple regression analyses were performed for the dynamic predictor variables for the High 
FPA foot.   Predictor variables for the first dynamic hierarchical multiple regression analysis 
(Dynamic Model A) were thigh to lab external (lateral) rotation, peak hind foot on shank (ankle) 
dorsiflexion, peak hallux on forefoot (1st MTPJ) extension, and peak ankle plantar flexor power.  
Dynamic Model A predictor variables were selected a priori based on previously reported 
relationships between slower gait speed and limited dynamic forefoot on hind foot (1st MTPJ) 
extension, of the hind foot on shank (ankle) dorsiflexion, and decreased ankle plantar flexor 
power in adults with DMPN10-14,16.  Group variables were also included into the model.  Order for 
model entry for dynamic predictor variables was based on the proximal to distal location of the 
joint in the lower extremity.  
To further assess any potential contribution of other candidate dynamic predictor 
variables not selected a priori for inclusion into a multiple regression analysis, we performed an 
additional hierarchical multiple regression analysis (Dynamic Model B). We analyzed the 
relationship between all candidate dynamic predictor variables of FPA on the High FPA foot 
using Pearson product moment correlation coefficient (r)6,38  and coefficients of determination 
(R2).  To determine the unique contributions of inter-segmental foot motion during walking to 
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FPA, hind foot on shank (calcaneal) eversion at mid stance as an indicator of frontal plane 
subtalar joint position, and forefoot on hind foot abduction at mid stance as an indicator of 
transverse plane forefoot position were also included into the multiple regression analysis of 
dynamic predictor variables.  Selection of these variables was based on previously reported 
decreases in frontal plane hind foot motion41, and fixed forefoot deformities (i.e., hammer toe 
deformity, hallux abducto-valgus, forefoot abduction on hind foot) in adults with DMPN39,42. The 
dynamic predictor variables measured at mid stance included in Dynamic Model B were thigh to 
lab external (lateral) rotation, shank to lab external (lateral) rotation,  hind foot on shank 
(calcaneal) eversion, and forefoot on hind foot abduction.  Group variables were also included 
into the model.  Order for model entry for dynamic predictor variables was based on the 
proximal to distal location of the joint in the lower extremity.   
3.4. Results 
3.4.a. Participant Characteristics  
The mean± SD age for all participants (N=45) was 60±10 years (range: 44-85 years). 
There were no group differences in age or height or body mass index (BMI)(Table 3.1). The 
DMPN+NPU group had been diagnosed with diabetes earlier and had greater loss of vibration 
perception than the DM group.  The DMPN-NPU and DMPN+NPU groups had a significantly 
greater vibration perception threshold than the DM and CON groups.  There were no between-
group differences in walking speed (p=.80).  The mean and standard deviations are shown in 
Table 3.1. 
3.4.b. Group comparisons   
The DMPN+NPU group had a greater FPA on the High FPA foot than the other groups 
(DMPN+NPU= -21±5⁰; DMPN-NPU=-13±7⁰; DM=-14±5⁰; CON=-15±6⁰, P=.03).  Posthoc testing 
revealed a difference between the DMPN-NPU and DMPN+NPU groups (p=.04), as well as a 
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trending difference between the DM and DMPN+NPU groups (p=.09).  The means and standard 
deviations are shown in Table 3.3.   
For the static predictor variables, the DMPN+NPU group had less total hip rotation and 
standing 1st MTPJ extension range of motion than the other participant groups (DMPN+NPUtotal 
hip= 58±17⁰; DMPN-NPUtotal hip= 69±16⁰; DMtotal hip= 80±12⁰; CONtotal hip =77±19⁰, p=.01; 
DMPN+NPU 1st MTPJ= 35±18⁰; DMPN-NPU 1st MTPJ = 55±11⁰; DM1st MTPJ = 61±7⁰; CON1st MTPJ 
=53±11⁰, p=.01).  There were no group differences in range of motion or position for the other 
static predictor variables.  The means and standard deviations for all static predictor variables 
are shown in Table 3.2. 
For the dynamic predictor variables, the DMPN+NPU group had less peak ankle plantar 
flexor power (p=.01) and peak hallux on forefoot (1st MTPJ) extension during the stance phase 
of gait compared to the other participant groups (p=.02).  There were no group differences in the 
other inter-segmental motion variables.  The means and standard deviations for all dynamic 
predictor variables are shown in Table 3.3.   
3.4.c. Hierarchical multiple regression analyses 
 Static model.  Selection of static predictor variables for inclusion into a hierarchical 
multiple regression analysis was based on the results of bivariate correlation and coefficient of 
determination analyses for the static predictor variables.  The coefficients of determination that 
associate static predictor variables with FPA in this model are shown in Table 3.4.  Total hip 
rotation and ankle dorsiflexion range of motion explained 8-10% of the variance in FPA.  
Resting calcaneal stance position (RSCP) explained 6% of FPA variance, a unique contribution 
that had a trend toward statistical significance (p=.05), and was therefore included into the 
model.        
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Table 3.6 illustrates the hierarchical multiple regression model for static predictor 
variables.  Four variables (total hip rotation range of motion, ankle dorsiflexion range of motion, 
RSCP, group) were selected for inclusion into the hierarchical multiple regression model for 
static predictor variables.  Multiple regression analysis for these four static predictors explain 
29% of FPA variance, but the unique contribution of each variable was not statistically 
significant (R2=.29, p>.05).  Additionally, the group differences in FPA and total hip rotation 
range of motion are not significant after the static predictors are partialed out.  Based on our 
criteria, none of the static predictor variables contribute to FPA variance. 
 Dynamic model A.  Dynamic predictor variables for inclusion into a hierarchical multiple 
regression analysis were selected a priori.  Table 3.7 illustrates the dynamic multiple regression 
analysis of the a priori variables (Dynamic Model A).  Multiple regression analysis for the 
dynamic predictors explain 37% of FPA variance (R2=.37, p<.05), but the unique contribution of 
thigh external (lateral) rotation at mid stance explains 23% of FPA variance (p<.01).  The 
combined contribution of the remaining predictor variables was 14%, but their unique 
contribution to FPA was not significant (p>.05). 
Dynamic Model B.  The coefficients of determination that associate the dynamic 
predictor variables with FPA in this model are shown in Table 3.5.  Thigh external (lateral) 
rotation and shank external (lateral) rotation at mid stance explained 20-33% of FPA variance. 
Table 3.8 illustrates the dynamic multiple regression analysis of the added dynamic predictor 
variables.  Multiple regression analysis for the dynamic predictors in this model explain 48% of 
FPA variance (R2=.48, p<.05).  The unique contribution of thigh and shank external (lateral) 
rotation at mid stance accounts for 37% of FPA variance (p<.01).  Shank to lab external (lateral) 
rotation uniquely contributed 16% of FPA variance (R2 change=.16, p=.01). The addition of hind 
foot on shank eversion, forefoot on hind foot abduction, and group classification did not predict 
FPA. 
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3.5 Discussion 
This is the first investigation to determine static and dynamic predictors of FPA in a 
population of adults with and without DMPN.  Additionally, this study is the first to determine the 
unique and collective contribution of goniometric measurements of hip rotation to a 
spatiotemporal gait variable across a spectrum of individuals with and without diabetes mellitus.  
Key findings from this study are that in adults with DMPN, static goniometric measures of lower 
extremity alignment and joint mobility do not predict FPA.  However, dynamic inter-segmental 
external (lateral) rotation of the thigh and shank obtained at the mid stance phase of gait 
predicted 37% of variance in FPA in adults with DMPN.  Furthermore, inter-segmental foot 
motion did not predict FPA in either dynamic hierarchical multiple regression model (Dynamic 
Model A, Dynamic Model B).   
3.5.a.  Static predictors.  Static predictors of FPA in the current study are select 
goniometric measures of alignment and mobility of select lower extremity joints.  One of the 
purposes of this study was to identify impairment-based predictor variables that contribute to 
FPA at mid stance in participants with and without DMPN and a prior history of ulceration.  
Static predictors did not contribute to FPA variance despite limitations in hip rotation and ankle 
dorsiflexion in the DMPN+NPU group compared with the other participant groups.  These 
findings suggest that static measures of alignment and limited joint mobility at the foot and ankle 
are not predictive of foot placement during gait in adults with or without DMPN and a prior 
history of ulceration.  Static measures of limited joint mobility (LJM) are often used to assess 
risk for elevated regional plantar stresses and loads in individuals with DMPN23,24.  Given the 
previously reported relationship between static measures of LJM at the foot and ankle and 
elevated regional PPP11,23,24, static measurement of LJM in individuals with DMPN may better 
predict regional plantar stresses than FPA. 
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3.5.b.  Dynamic predictors.   In the current investigation, thigh and shank external 
(lateral) rotation position at mid stance predicted 37% of the variance in FPA.  Shank external 
(lateral) rotation position at mid stance was the strongest predictor of FPA, having a unique 
contribution of 16% to FPA variance.  Furthermore, dynamic measures of inter-segmental foot 
mobility, namely hind foot on shank (ankle dorsiflexion, hind foot on forefoot (calcaneal) 
eversion, forefoot on hind foot abduction, and hallux on forefoot (1st MTPJ extension) did not 
predict FPA in either hierarchical multiple regression analysis.   Lee et al reported that knee 
(shank on thigh) external rotation during gait was moderately correlated with FPA in children 
with cerebral palsy22.  Our findings are similar in that external rotation of the thigh and shank 
segments best predict FPA in adults with and without DMPN and a prior history of ulceration.  
Ho et al reported that healthy children with a large external FPA demonstrated greater ankle 
dorsiflexion motion during gait compared with children with “normal” FPA21.  In this study, hind 
foot on shank (ankle) dorsiflexion motion during gait did not predict FPA in adults with and 
without DMPN and a prior history of ulceration.   These findings suggest that rotation of the 
proximal segments may better predict FPA than distal lower extremity segments in adults with 
DMPN.  Rao et al reported that dynamic measures of dynamic 1st MTPJ extension accounts for 
20% of plantar stresses under the hallux in adults with DMPN43.  Although there is considerable 
evidence identifying foot motion variables as dynamic predictors of elevated regional plantar 
stresses and loads, inter-segmental foot motion variables do not predict FPA.   
In the current study, dynamic measures of hind foot on shank (ankle) dorsiflexion, hind 
foot on shank (calcaneal) eversion, forefoot on hind foot abduction, and hallux on shank (1st 
MTPJ) extension did not predict FPA.   A possible explanation could be the moderate to strong 
associations of shank external (lateral) rotation with peak ankle plantar flexor power, hind foot 
on shank (calcaneal) eversion at mid stance, forefoot on hind foot abduction at mid stance, and 
peak hallux on forefoot (1st MTPJ) extension.   The association between shank external (lateral) 
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rotation and hind foot on shank eversion is illustrative of the coupled motions of shank external 
(lateral) rotation with hind foot eversion during the stance phase of gait reported in previous 
investigations44-46.  Rao et al (2007) reported no differences in segmental motion of the shank 
during the stance phase of gait between participants with and without diabetes, which they 
suggest augments the differences in hind foot eversion and fore foot sagittal plane motion41.  
Findings from the current study suggest that transverse plane motion of the shank at mid stance 
is greater in the DMPN+NPU, and is moderately correlated with proximal and distal inter-
segmental foot motion.  The correlation between shank external (lateral) rotation and dynamic 
predictor variables manifests as more robust contribution of transverse plane shank motion to 
FPA variance.    
Interventions that target static and dynamic impairments in foot alignment and motion 
structural deformities within the scope of physical therapist practice are limited, and are often 
cost prohibitive22.  Identifying predictors of FPA could inform areas for clinical assessment and 
targets for treatment of lower extremity impairments earlier in the lower extremity impairment 
cascade to minimize risk of elevated plantar stresses that often lead to NPU development.  
Also, simple cost-effective rehabilitative interventions, like gait modification strategies, which 
incorporate movement of proximal lower extremity segments (i.e., the thigh and shank) could be 
effective in reducing plantar stresses in areas of the foot vulnerable to ulceration in adults with 
DMPN.    Future studies should examine the efficacy of physical therapy interventions such as 
gait modification, which may serve as a cost-effective strategy to reducing FPA magnitude, and 
subsequently lowering risk for NPU development in adults with DMPN.  
There are limitations associated with this study.  The first of these limitations is small 
sample size using a four-group design. A larger sample size would allow a more thorough 
exploration of the many alignment and position variables that might predict FPA magnitude.  
Similarly, we did not include radiographic measures in the protocol primarily due to a lack of 
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previous indication for their utility in predicting FPA.  Given the reported relationship between 
radiographic alignment measures of the foot and ankle and elevated regional plantar stresses in 
adults with DMPN6,42, static alignment and bony abnormalities of the lower extremity may also 
be static predictors of FPA in adults with and without DMPN and a prior history of ulceration.  
3.6. Conclusions 
In adults with and without DMPN and a prior history of ulceration, dynamic (gait) 
variables best predict FPA.  External (lateral) rotation of the proximal segments (thigh and 
shank) at the mid stance phase of gait explained 37% of the variance in FPA.  Shank external 
(lateral) rotation had a unique contribution of 16% to FPA variance, therefore making it the 
strongest predictor of FPA.  Foot motion variables did not predict FPA in either hierarchical 
multiple regression model of dynamic variables, despite group differences in 1st MTPJ extension 
and ankle plantar flexor power.   Static, goniometric measures of limited joint mobility of the foot 
and ankle joints do not predict FPA in individuals with DMPN.  These findings suggest that 
identifying predictors of FPA could be clinically useful in informing where to focus assessments 
and interventions earlier in the lower extremity impairment cascade to minimize risk of elevated 
regional plantar stresses and load in adults with DMPN with and without a prior history of 
ulceration. 
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CON 
(N=12) 
 
DM 
(N=12) 
 
DMPN-NPU 
(N=11) 
 
DMPN+NPU 
(N=10) 
 
p 
Age (years) 60 (12) 58 (9) 63 (11) 58 (11) .80 
Height (m) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) .79 
Sex (M:F) 7:5 5:7 4:7 5:5 .95 
BMI (kg/m2) 33 (5)† 34 (8)# 39 (9) 41 (9) .08 
Disease duration (years) N/A 8 (5)# 11 (9)§ 24 (8) <.01 
Great Toe VPT (V) 20 (9)† 15 (6)# 37 (11) 34 (17) <.01 
Walking Speed (m/s) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) .80 
Side of greater FPA (R:L) 11R:1L 9R:3L 9R:3L 6R:4L -- 
Table 3.1.  Participant characteristics, mean (SD).  VPT: vibration perception threshold (Volts); 
Side of greater FPA (R:L): Number of right feet (R) or left feet (L) having a greater foot 
progression angle.  †,#,§:significance values for group differences.  Disease duration (years): †: 
CON versus DMPN-NPU and DMPN+NPU; #: DM versus DMPN+NPU; §: DMPN-NPU versus 
DMPN+NPU. Great Toe VPT (V): †: CON versus DMPN-NPU and DMPN+NPU; #DM versus 
DMPN-NPU and DMPN+NPU;  
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 CON 
(N=12) 
 
DM 
(N=12) 
 
DMPN-NPU 
(N=11) 
 
DMPN+NPU 
(N=10) 
 
p 
Total hip rotation ROM*  77 (19)† 80 (12)# 69 (16)§ 58 (17) .01 
Ankle dorsiflexion ROM 8 (5) 9 (5) 8 (4) 5 (4) .20 
RCSP 4 (2) 2 (4) 4 (5) 4 (5) .78 
1st MTPJ extension  53 (11)† 61 (7)# 55 (11)§ 35 (18) .01 
 
Table 3.2.  Static (goniometric) measures for the foot with the greater foot progression angle 
(High FPA).  Values are expressed in degrees, mean (SD).  Motion variables. Total hip rotation 
ROM is the sum of range of motion values for hip internal and external rotation. Ankle 
dorsiflexion ROM is goniometric ankle dorsiflexion range of motion measurement in non-weight 
bearing (prone lying).  Resting calcaneal stance position (RCSP) is measure of calcaneal 
position relative to the floor in standing.  1st metatarsophalangeal joint is extension range of 
motion measurement assessed in standing.  Reported significance values (p) are overall group 
comparisons; †,#,§:significance values for group differences.  Total hip excursion: †: CON 
versus DMPN+NPU; #: DM versus DMPN+NPU; §: DMPN-NPU versus DMPN+NPU.  Standing 
1st MTPJ extension: †: CON versus DMPN+NPU; #: DM versus DMPN+NPU;  §: DMPN-NPU 
versus DMPN+NPU 
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 CON 
(N=12) 
 
DM 
(N=12) 
 
DMPN-NPU 
(N=11) 
 
DMPN+NPU 
(N=10) 
 
p 
FPA  -15 (6) -14 (5) -13 (7)§ -21 (5) .03 
Thigh rotation  -1 (9) -6 (9) -4 (13) -9 (7) .30 
Shank rotation  -4 (13) -8 (9) -9 (14) -16 (8) .17 
Peak HF on Shank DF 9 (5) 9 (5) 8 (5) 13 (3) .13 
Peak ankle PF power  2 (1)† 2 (1)# 2 (1)§ 1 (1) .01 
HF on Shank EV -7 (9) -4 (6) -6 (6) -2 (5) .22 
Peak hallux on FF EXT  34 (7)† 31 (9)# 33 (6)§ 23 (9) .02 
FF on HF ABD -6 (7) -3 (6) -3 (9) -5 (8) .71 
Walking speed (m/s) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) 1.0 (0.4) .74 
Table 3.3. Dynamic (gait kinematic and kinetic) measures for the foot with the greater foot 
progression angle (High FPA).  Kinematic values are expressed in degrees, mean (SD).  Peak 
ankle plantar flexor power is expressed in Watts/kg, mean (SD). Motion variables. FPA is the 
foot progression angle on the High FPA foot, (-)=toe-out angle; Thigh rotation:  Thigh segment 
external rotation (-) value at mid stance; Shank rotation: Shank segment external (-) rotation 
value at mid stance; Peak HF on Shank DF: the peak value of hind foot on shank (ankle) 
dorsiflexion (+) during stance; Peak ankle PF power: the peak value of ankle plantar flexor 
power generation (+) during stance; HF on Shank EV: hind foot on shank (calcaneal) eversion (-
) value at mid stance; Peak hallux on FF EXT:  the peak value of hallux on forefoot (1st MTPJ) 
extension (+) during stance; FF on HF ABD: forefoot on hind foot abduction (-) at mid stance.  
Reported significance values (p) are overall group comparisons.   †,#,§:significance values for 
group differences. FPA: §: DMPN-NPU versus DMPN+NPU; Peak Ankle PF Power: †: CON 
versus DMPN+NPU; #: DM versus DMPN+NPU; §: DMPN-NPU versus DMPN+NPU; Peak 
Hallux on FF EXT: †: CON versus DMPN+NPU; #: DM versus DMPN+NPU; §: DMPN-NPU 
versus DMPN+NPU 
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 FPA 
Total hip 
rotation 
ROM 
Ankle 
dorsiflexion 
ROM 
RSCP 1
st MTPJ 
extension
FPA - .08* .10* .06 .01 
Total hip rotation ROM .08* - .25** .00 .18** 
Ankle dorsiflexion ROM .10* .25** - .00 .16** 
RSCP .06 .00 .00 - .00 
1st MTPJ extension .01 .18** .02 .00 - 
 
 
 
Table 3.4.  Coefficients of determination (R2) values between the static predictor variables and 
foot progression angle (FPA) for the foot with the greater foot progression angle (High FPA).  
Motion variables. Total hip rotation ROM is the sum of range of motion values for hip internal 
and external rotation. Ankle dorsiflexion ROM is goniometric ankle dorsiflexion range of motion 
measurement in non-weight bearing (prone lying).  Resting calcaneal stance position (RCSP) is 
measure of calcaneal position relative to the floor assessed in standing. 1st 
metatarsophalangeal joint is extension range of motion measurement assessed in standing.  *: 
significance level (1-tailed), p<.05; **: p<.01 
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FPA Thigh rotation 
Shank 
rotation 
Peak HF 
on 
Shank 
DF 
Peak 
ankle 
PF 
power 
HF on 
Shank 
EV 
Peak 
hallux on 
FF EXT 
FF on 
HF ABD 
FPA  - .45** .58** -.26 .32 -.27 .15 .01 
Thigh 
rotation  .20** - .86** -.22 .37* -.32* .32 -.17 
Shank 
rotation  .34** .86** - -.23 .40** -.37* .33* -.34* 
Peak HF on 
Shank DF .07 -.22 -.23 - -.40** .21 -.24 -.05 
Peak ankle 
PF power .10 .37* .40** -.40** - -.36* .48* -.05 
HF on 
Shank EV .07 -.32* -.37* .21 -.36* - -28 -.01 
Peak hallux 
on FF EXT .02 .32 .33* -.24 .48* -28 - -.29 
FF on HF 
ABD  .00 -.17 -.34* -.05 -.05 -.01 -.29 - 
Table 3.5.  Coefficients of determination (R2) values between the dynamic predictor variables 
and foot progression angle (FPA) for the foot with the greater foot progression angle (High 
FPA).    Motion variables.  FPA:  the foot progression angle on the High FPA foot, (-)=toe-out 
angle; Thigh rotation: Thigh segment external rotation (-) value at mid stance; Shank rotation:  
Shank segment external (-) rotation value at mid stance; Peak HF on Shank DF: the peak value 
of hind foot on shank (ankle) dorsiflexion (+) during stance; Peak ankle PF power: the peak 
value of ankle plantar flexor power generation (+) during stance; HF on Shank EV: hind foot on 
shank (calcaneal) eversion (-) value at mid stance; Peak hallux on FF EXT:  the peak value of 
hallux on forefoot (1st MTPJ) extension during stance; FF on HF ABD: forefoot on hind foot 
abduction (-) at mid stance.   
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Variables 
Unstandardized 
beta 
(95% CI) 
Standardized 
beta R
2 R
2 
change 
Sig. F 
Change 
(Constant) -18.73 
(-30.52,-15.00) N/A N/A N/A <.01 
Total hip rotation ROM .03 (-.09, .15) .09 .08 .08 .07 
Ankle dorsiflexion ROM .15 (-.22, .52) .13 .12 .04 .18 
RSCP -.41 (-.91, .09) -.25 .18 .06 .10 
d1 (DM) 
 
d2 (DMPN-NPU) 
 
d3 (DMPN+NPU)  
 
.38 
(-4.67, 5.42) .03    
2.55 
(-2.89, 7.99) .17 
 
   
-4.02 
(-10.04, 1.99) -.27 
 
.29 
 
.11 .15 
Table 3.6.  Hierarchical multiple regression analysis of static (goniometric) predictors of foot 
progression angle (FPA) on the foot with the greater FPA (High FPA).  Variables are listed in the 
order of entry. Motion variables. Total hip rotation ROM is the sum of range of motion values 
for hip internal and external rotation. Ankle dorsiflexion ROM is goniometric ankle dorsiflexion 
range of motion measurement in non-weight bearing (prone lying).  Resting calcaneal stance 
position (RCSP) is measure of calcaneal position relative to the floor assessed in standing.  1st 
metatarsophalangeal joint is extension range of motion measurement assessed in standing. 
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Variables 
Unstandardized 
beta 
(95% CI) 
Standardized 
beta R
2 R
2 
change 
Sig. F 
Change 
(Constant) -15.47 (-26.01,-4.80) N/A N/A N/A <.01 
Thigh rotation  .24 (.06, .45) .37 .23* .23 <.01 
Peak HF on Shank DF -.02 (-.52, .30) -.08 .25 .05 .26 
Peak hallux on FF EXT .04 (-.15, .88) .05 .26 .03 .45 
Peak ankle PF power .08 (-2.14, 3.39) .19 .29 .03 .25 
d1 (DM) 
 
d2 (DMPN-NPU) 
 
d3 (DMPN+NPU)  
 
1.92 
(-2.89, 6.74) .14    
2.58 
(-2.26, 7.41) .18    
-3.01 
(-8.85, 2.83) -.20 
 
.37 
 
.08 .30 
 
Table 3.7. Hierarchical multiple regression analysis of dynamic (gait kinematic and kinetic) 
predictors of foot progression angle (FPA) on the High FPA foot (Dynamic Model A).  Variables 
are listed in the order of entry. Motion variables.  Thigh rotation: Thigh segment external 
rotation (-) value at mid stance; Peak HF on Shank DF: the peak value of hind foot on shank 
(ankle) dorsiflexion (+) during stance; Peak hallux on FF EXT:  the peak value of hallux on 
forefoot (1st MTPJ) extension (+) during stance; Peak ankle PF power: the peak value of ankle 
plantar flexor power generation (+) during stance. d1,d2,d3: Coding for group classification with 
CON participants as the reference group.   d1: DM group; d2: DMPN-NPU group; d3: 
DMPN+NPU group 
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Variables 
Unstandardized 
beta 
(95% CI) 
Standardized beta R2 R
2 
change 
Sig. F 
Change 
(Constant) -13.63 (-15.0,-12.2) N/A N/A N/A <.01 
Thigh rotation  -.15 (.46, .16) -.24 .21* .23 <.01 
Shank rotation  .40 (.10, .70) .75 .37* .16 <.01 
HF on Shank EV -.10 (-.16, .29) -.11 .39 .05 .32 
FF on HF ABD  .06 (-1.45, 7.05) .08 .41 .03 .26 
d1 (DM) 
 
d2 (DMPN-NPU) 
 
d3 (DMPN+NPU)  
 
1.62 
(-2.60, 5.84) .12    
2.80 
(-1.45, 7.05) .20    
-1.84 
(-6.48, 2.79) -.13 
 
.48 
 
.07 .20 
 
Table 3.8.  Hierarchical multiple regression analysis of dynamic (gait kinematic and kinetic) 
predictors of foot progression angle (FPA) on the High FPA foot (Dynamic Model B).  Variables 
are listed in the order they were entered into the multiple regression analysis.  Motion 
variables.  Thigh rotation: Thigh segment external rotation (-) value at mid stance; Shank 
rotation:  Shank segment external (-) rotation value at mid stance; HF on Shank EV: hind foot on 
shank (calcaneal) eversion (-) value at mid stance; FF on HF ABD: forefoot on hind foot 
abduction (-) at mid stance.  d1,d2,d3: Coding for group classification with CON participants as 
the reference group.  d1: DM group; d2: DMPN-NPU group; d3: DMPN+NPU group 
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B.  Thigh rotation 
A . FPA  
 C. Shank rotation D.  HF on Shank (ankle)  
E.  Ankle PF Power F. Hallux on FF (1st MTPJ) 
H. FF on HF (forefoot) 
G. HF on Shank (calcaneal) 
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Figure 3.1.  Time series motion graphs of dynamic predictor 
walking. The blue line and shaded region represents the mean± 1 standard deviation of the 
motion for the CON group.  Boxed regions represent values used in the analysis. Figure 
legend. CON: non-diabetic control participants; DM: diabetes mellitus without peripheral 
neuropathy group; DMPN-NPU: diabetes mellitus with peripheral neuropathy without a previous 
neuropathic plantar ulcer; DMPN+NPU: diabetes mellitus with peripheral neuropathy with a 
previous neuropathic plantar ulcer.  Motion variables.  A. FPA:  FPA on the High FPA foot (-
)=toe-out angle; B.  Thigh rotation: Thigh segment internal (+)/external rotation (-) ; Shank 
rotation:  C.  Shank segment internal(+)/external(-) rotation; D.  HF on Shank (ankle): Hind foot 
on shank (ankle) dorsiflexion (+)/plantarflexion (-); E.  Ankle PF power: Ankle plantar flexor 
power generation (+)/absorption(-); F.  Hallux on forefoot (1st MTPJ) extension (+)/flexion (-); G. 
t): 
 
variables during the stance of 
HF on Shank (calcaneal): Hind foot on shank inversion (+)/eversion (-); H. FF on HF (forefoo
Forefoot on hind foot adduction (+)/abduction (-). 
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Impact of foot progression angle modification on plantar loading in individuals 
with diabetes mellitus and peripheral neuropathy 
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4.1. Abstract 
 the United States, an estimated 12 to 25% of patients with diabetes mellitus and peripheral 
isk of neuropathic plantar ulcer (NPU) development.   Peak 
plantar pressure (PPP) is often used as an index of risk for NPU development in individuals with 
MPN.  Previous groups have reported a direct relationship between an excessive external foot 
rogression angle (FPA) and the magnitude of regional PPP in adults with DMPN.  However, it 
is unknown if FPA is modifiable in diabetes mellitus, or the effects of such a modification on 
regional PPP.  The purposes of this study were to determine: 1) if participants with diabetes 
ellitus can reduce FPA, and 2) the impact of the reduction of FPA on the magnitude of PPP.  
individuals with diabetes were classified as having: 1) diabetes mellitus without 
peripheral neuropathy (DM), and 2) DMPN with a prior history of NPU (DMPN+NPU). 
t their preferred FPA (pFPA), and with their foot in a corrected, or reduced, 
t 
ion 
cant 
1,2  ha
In
neuropathy (DMPN) have a lifetime r
D
p
m
Twenty-one 
Participants walked a
FPA position (cFPA).  The cFPA was reduced from the pFPA in both groups, but only significan
for the DM group (Mean±SE; DMpFPA=-13±2⁰, DMcFPA=4±3⁰, p=<.01; DMPN+NPUpFPA=-16±2⁰; 
DMPN+NPUcFPA=-11±4⁰, p=.13).  The DM group demonstrated a 32% reduction in medial 
forefoot PPP in the cFPA versus the pFPA condition that trended toward statistical significance 
(Mean±SE; DMpFPA=44±11 N/cm2, DM=30±14 N/cm2, p=.07).  Our findings highlight the 
potential utility for FPA modification in adults with diabetes mellitus as a therapeutic intervent
for offloading areas of the foot at risk for NPU development.    
4.2. Introduction  
The development and recurrence of neuropathic plantar ulcers (NPUs) are a signifi
health and economic burden worldwide.  In the United States, an estimated 12 to 25% of 
individuals with diabetes mellitus and peripheral neuropathy (DMPN) have a lifetime risk of NPU 
development .  Previous studies ve shown that individuals with DMPN with history of NPU 
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have greater peak plantar pressure (PPP) in the forefoot region compared to those who did
not3,4.  Those with a history of NPU have the highest relative risk for re-ulceration of the 
previous healed NPU or ulcer development in an alternative location (RR=2.46; 95% CI: 
3.29)5  Over 65,000 non-traumatic lower extremity amputations in adults with DMPN are 
performed annually in the United States, 84% of which are prec
 
1.84-
eded by NPUs6,7.   
Numerous treatment strategies have been employed for offloading plantar sites to promote 
NPU healing and to prevent re-ulceration.  Commonly used offloading strategies include use of 
cus ct 
ade 
ategies 
ls with 
t for NPUs, 
ext
 
tom-made insoles or other shoe modifications8, removable cast walking boots, total conta
casting, and non-weight bearing strategies such as wheelchair usage9.  Though custom m
insoles, total contact casts, and removable cast walking boots have been shown to successfully 
reduce forefoot and mid foot peak plantar pressure in individuals with DMPN and a history of 
NPU 8,10, there are often barriers related to cost, patient compliance, and reimbursement 9,11.  
Much of the previous research reports the efficacy of these interventions as treatment str
for healing existing NPUs12.  Moreover, non-weight bearing offloading techniques potentially 
contribute to the development and progression of mobility limitations reported by individua
diabetes6.  Though offloading strategies may provide the proper healing environmen
ensive periods of offloading may make the skin on the plantar surface of the foot vulnerable 
to re-injury, as evidenced by the high rates of re-ulceration (~20-70%) after successful healing 
with offloading13,14.   
In addition to casting, orthotics, and footwear treatment options, researchers have also 
examined the effectiveness of modifying gait patterns on reduction of PPP in healthy young 
adults and in adults with DMPN11,15,16.   Gait modification strategies for older adults with DMPN
include walking slower, reducing push off in late stance phase of walking by exaggerating hip 
flexion15, or walking with a “step-to” gait pattern16.  Though these strategies reduce PPP in the 
forefoot, reported changes in other regions of the plantar surface of the foot are variable15,16.  
Foot progression angle (FPA), or “toe-out angle,” is the orientation of the longitudinal axis of the 
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foot in the transverse plane with respect to the direction of progression during gait17,18. 
Investigators have reported a direct relationship between excessive external FPA and elevated 
medial PPP in children with neurological impairments, and with the timing and magnitude of 
medial and lateral PPP in adults with DMPN19-21.  However, there have been no reports as to 
whe
4.3.a. Subjects 
 
e of 
.  The 
 
ild and severe impairment in sensation and foot 
function.  The presence or absence of peripheral neuropathy was assigned based on the 
of protective sensation, and ulcer classification was based on any prior 
history of plantar ulceration. Peripheral neuropathy was assessed using a 5.07 (10 gram) 
ther an excessive FPA is modifiable in individuals with diabetes mellitus with or without 
peripheral neuropathy, or the effects of such a modification on regional PPP.  Therefore, the 
purposes of this study were to: 1) determine if participants with diabetes mellitus with and 
without peripheral neuropathy and a history of NPU can reduce their excessive FPA with a 
simple intervention of verbal and visual cueing, and 2) determine the impact of FPA reduction 
on regional PPPs in adults with diabetes.  We hypothesized that reduction of FPA in both 
groups would result in concomitant decreases in the magnitude of PPP on the medial forefoot 
mask on the plantar surface of the foot.    
 
4.3. Methods  
Twenty-one individuals with diabetes (10 men, 11 women; Mean±SE; age, 59±2.0 years; 
height, 1.7±0.1 m; BMI, 37±2 kg/m2) participated, and provided written informed consent as
approved by our university’s Institutional Review Board.   Participants were classified into on
two groups: 1) diabetes mellitus without peripheral neuropathy (DM), and 2) diabetes mellitus 
and peripheral neuropathy with a prior history of a neuropathic plantar ulcer (DMPN+NPU)
purpose for selecting these groups was to determine the effect of reducing FPA in a population
of adults with diabetes that demonstrated m
presence or absence 
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Semmes-Weinstein monofilament at seven sites on the plantar surface of the foot22.  In addition, 
we measured vibration perception threshold (VPT) using a 120 V bioesthesiometer (Bio-medical 
Those who were either unable to feel the 10 gram monofilament on at least one of the seven 
sites on the foot, or were unable to perceive vibration of the bioesthesiometer at threshold of 25 
V or greater were classified as having peripheral neuropathy.  A VPT >
Instrument Co., Newbury, OH, 44065, USA) to assess large fiber peripheral nerve function.  
25 V is associated with 
23
these tests for protective sensation has been shown to increase specificity of risk identification 
and disease severity without diminution in sensitivity23.  Eleven participants were classified as 
history of unilateral ulceration and 2 reported a history of bilateral ulceration. Participants 
classified as DMPN+NPU were not ulcerated at the time of testing.  Those identified as non-
study. 
(Novel Inc., St. Paul, MN, USA).  System specifications include a sampling frequency of 50Hz 
and resolution of 2 sensors/cm for a network of 2736 sensors.  Participants were selected to 
a 3.6 m walkway at their self-selected speed and preferred FPA (pFPA).   Participants were 
then verbally directed to align their foot along the 2  ray (representing the longitudinal axis of 
with their foot in this corrected position (cFPA) over the walkway their self-selected speed.  
Participants were also given verbal instructions to “keep their feet turned straight” prior to 
practice trials.  Walking speed was measured using a stopwatch over a predetermined distance, 
incidence of foot ulceration in individuals with Type 2 diabetes mellitus . The combination of 
DM, and ten were classified as DMPN+NPU.  Of the DMPN+NPU participants, 8 reported a 
ambulatory or with lower extremity amputations proximal to the digits were excluded from the 
4.3.b. Procedure 
Dynamic plantar pressures were collected using an EMED-ST-P-2 pedobarograph 
2 
walk under two conditions using the 2-step method 24. Participants were first asked to walk over 
nd
the foot) on a thickened black line in the floor parallel with the line of gait progression and walk 
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and is expressed in meters/min.  Participants performed three walking trials with each foot 
contacting the EMED platform during each condition.  All participants were allowed 1-2 practice 
4.3.c.1.  FPA measurement.  FPA was calculated as measured angle between the line 
posterior bisection of the foot extending from the center of the hind foot through the 2 /3  rays 
obtained from the plantar pressure map using a 2⁰ increment goniometer .  A change of ≥4⁰ 
was considered a meaningful corrected change in FPA based on reported ranges of 5-9⁰ for 
FPA magnitude and 1-2⁰ for FPA asymmetry in young and older adults .  The threshold of ≥4⁰ 
was, therefore, the desired response to visual and verbal cues with several practice trials.    
proximately between the 2nd and 3rd rays, 
creating medial (Med) and lateral (Lat) vertical masks using Percent Mask software (Novel Inc., 
St. Paul, MN, USA).  The plantar map was further divided into three horizontal regions at 33% 
and 63
 
s
 
elevated regional PPP values occur at areas of skin breakdown in individuals with diabetes that 
have a lack of protective sensation and a history of neuropathic ulceration19
trials prior to recording.  
4.3.c. Data processing and statistical analysis 
of progression (a line drawn parallel to the printed paper) and the line representing the anterior-
nd rd
20
25
4.3.c.2.  Masks of Pressure map.  The pressure map of each foot step was first divided 
into two regions using a 50% vertical bisector ap
% of foot length creating masks at the heel (Heel), mid foot (Mid) and forefoot (Fore).  
The vertical and horizontal bisections of the foot created six distinct masks: the medial and 
lateral forefoot (Med Fore, Lat Fore), the medial and lateral mid foot (Med Mid, Lat Mid), and the
medial and lateral heel (Med Heel, Lat Heel).   The variable of interest wa  peak plantar 
pressure (PPP) which we use to operationally define stress based on previous work8.  PPP is
the peak pressure recorded within a mask region during stance phase of the gait cycle8.  PPP 
has been accepted as an index of risk for dermal injury on the foot plantar surface because 
. Force-time integral 
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(FTI) is a description of force expressed as a calculated sum of the product of pressure 
recorded from each sensor multiplied by the area and contact time of each sensor (∑(pressure 
X area X time)) for each region of the plantar surface of the foot8  
a history of bilateral involvement, the foot with the most recent ulceration was classified as the 
using IBM SPSS Statistics software, version 21.0 (SPSS Inc, Chicago, IL, USA).    
PPP and FTI for the Inv foot was averaged over three trials, and statistically analyzed 
using a repeated measures, mixed-model analysis of covariance (ANCOVA).  There was
difference in walking speed between conditions for either group, but there was a between-group
difference in walking speed for both conditions.  Therefore, an ave
4.3.c.3.  Statistical analysis.  Participants’ feet were designated as Involved (Inv) for 
the DMPN+NPU group based on the foot with an ulcer history.  If DMPN+NPU participants had 
Inv foot.  Comparisons were made between the Inv foot of the DMPN+NPU group and a 
randomly assigned foot of participants in the DM group.  Statistical analyses were performed 
 no 
 
rage walking speed (mean 
walking speed=49 m/min) was used as a covariate to account for the established influence of 
walking speed on PPP as well as the between-group differences in walking speed (Table 1) .  
factors were condition (pFPA versus cFPA), mediolateral mask location (Mask A: Lat versus 
Med), and anteroposterior mask location (Mask B: Fore versus Mid).  Only the forefoot and mid 
development .  Post-hoc analyses for main and interaction effects were conducted using a 
Bonferr
4.4. Results 
26
The between-groups factor was group (DM versus DMPN+NPU), and the repeated measures 
foot masks were included in the analyses because these regions are most vulnerable to NPU 
11,27
oni correction, with statistical significance for all analyses set at p<.05. 
4.4.a. Participant Characteristics  
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The mean ± SE age for all participants (N=21) was 59±2 years (range: 43-76 years). 
There were no group differences in age, DM, height, or body mass index (BMI) (Table 1). The 
DMPN+NPU group had a longer duration of diabetes and greater vibration perception thresho
(VPT) on the Inv foot than the DM group, confirming the presence of peripheral neuropathy. 
There were between-group differences in walking speed, with the DM group walking faster tha
the DMPN+NPU group under both conditions (Table 4.1).   
ld 
n 
 
ssion Angle  
The DM group showed a significant reduction in FPA between conditions (Mean±SE; 
pFPA=-13±2⁰, cFPA=4±3⁰; p<.01).  Though the DMPN+NPU group overall achieved the 
meanin
to achieve the meaningful corrected change in FPA magnitude.  Two of eleven participants 
(18%) in the DM group and five of ten participants (50%) in the DMPN+NPU had a FPA of ≥10⁰ 
in the cFPA condition.  Of the five DMPN+NPU participants with an FPA of ≥10⁰ in the cFPA 
ondition, three of them did not achieve the meaningful corrected change of 4⁰.  There were 
onstrated reductions in FPA that resulted in the 
develop  a 
 
4.4.b. Foot Progre
gful corrected change in FPA magnitude of at least 4⁰, the reduction in FPA was not 
statistically significant (pFPA=-16±2⁰, cFPA=-11±4⁰; p=.13).  Nine participants out of eleven 
(82%) in the DM group and seven of ten participants (70%) in the DMPN+NPU group were able 
c
participants in both groups that dem
ment of an internal FPA (“toe-in” angle), a positive numeric value.  The DM group had
greater magnitude of absolute change between conditions compared to the DMPN(+)NPU
group, but these differences were not statistically significant (DM: 16±3⁰, DMPN+NPU:  9±2⁰, 
p=.14). Values are shown in Table 4.2.   
 
4.4.c. Peak Plantar Pressure 
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Values for PPP in each mask region are in Table 4.3. There was a statistically significa
four-way interaction of Condition x Group x Mask A (Lat versus Med) x Mask B (Fore versus 
Mid) (p=.0.02).  Figure 4.1 illustrates the peak plantar pressure profiles for the DM an
DMPN+NPU groups.  DM participants reduced PPP in the medial forefoot and increased PPP in 
the lateral mid foot in the cFPA condition compared with the pFPA condition.  The DMPN+N
group showed very little change in pressure in any region as a function of FPA correction.  Po
hoc comparisons verified this pattern, alb
nt 
d 
PU 
st 
eit only at marginally significant levels.  There was a 
32% decrease in the Med Fore mask in the DM group (pFPA=44 N/cm2, cFPA=30 N/cm2; 
% increase in the Lat Mid mask (pFPA=21 N/cm2, cFPA=35 
N/cm2;
4. 
estigation to determine the impact of FPA modification on plantar 
loading in participants with diabetes with and without peripheral neuropathy and plantar 
ings from this investigation was that both groups overall achieved 
forefoot (Med Fore) mask, a region shown to be at risk for ulceration in adults with DMPN, to the 
p=.07), with an accompanying 62
 p=.07).  Regional changes in PPP in the DM group demonstrated trends toward 
statistical significance.   
 
4.4.d. Force-Time Integral 
 There was a significant Condition X Mask B interaction (Fore versus Mid, p=.04).  There 
was a decrease in FTI in the forefoot from the pFPA to the cFPA condition (pFPA=139 N/cm2, 
cFPA=130 N/cm2, p=.02), with an increase in FTI in the mid foot (pFPA=68 N/cm2, cFPA=76 
N/cm2, p=.01).  No other effects were statistically significant.  Values are shown in Table 4.
 
4.5. Discussion 
This is the first inv
ulceration.  One of the key find
a clinically meaningful reduction of at least 4⁰ in their FPA with visual and verbal cueing.  
Another key finding was that both groups had a characteristic pressure shift from the medial 
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lateral mid foot (Lat Mid) mask as a result of the reduction in FPA.  However, larger difference
in PPP were observed in the DM group.  These findings indicate that use of a simple gait 
s 
odification strategy of reducing FPA may be a potentially effective therapeutic strategy to 
in areas of the foot vulnerable to dermal injury in adults with diabetes 
mellitus prior to the onset of peripheral neuropathy and the development of a neuropathic 
plantar ulcer.  
ps 
 
rent 
pands these findings by investigating the effects of implementing a similar gait 
modification in participants with diabetes with and without peripheral neuropathy.  In our study, 
both groups experienced a shift in PPP from the medial forefoot to the lateral mid foot, though 
participants in the DM groups had a greater magnitude of these changes compared to the 
DMPN+NPU group. The differences in the magnitude of the regional changes in PPP between 
groups could be attributed to limitations in hip and ankle range of motion29,30.  Additionally, the 
increase in regional PPP in the lateral mid foot in both groups were well below PPP values 
reported by Sinacore et al (2008) for classifications of lateral column foot deformities in 
individuals with DMPN27.   
m
modify plantar stresses 
In the current study, we observed a pattern of reduction in medial forefoot PPP 
(DM=32%; DMPN+NPU=8%), with a notable increase in lateral mid foot PPP in both grou
(DM=62%; DMPN+NPU=21%).  Other research groups have reported similar patterns of 
reduction in forefoot PPP using various gait modification strategies. Mueller and colleagues 
have reported reductions in in-shoe forefoot PPP by 27-53% and increases in heel PPP by 24%
using “hip flexion” and “step-to” gait modification strategies15,16. The authors, however, 
acknowledge these types of gait modifications impair movement symmetry and gait speed. 
Rosenbaum (2013) reported that manipulation of FPA yielded a 54% decrease in medial 
forefoot PPP and a 75% increase in lateral mid foot PPP as a result of in-toeing28.  The cur
investigation ex
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In recent years, there has been an expansion in the number of treatment options for 
offloading areas of the foot vulnerable to NPU development in individuals with DMPN.  In a 
review by Bus et al (2008), there is evidence supporting the efficacy of custom made insoles, 
total contact casts, and removable cast walkers for reducing forefoot PPP compared to stan
footwear.  Percentages of reduction in forefoot PPP range from 10-19% for custom made 
insoles13.  In the current investigation, we observed greater reductions in medial forefoot PPP 
using FPA reduction as a gait modification strategy.  Findings from this investigation 
demonstrate the potential for achieving similar decreases in areas of the foot vulnerable
dermal injury in adults with 
dard 
 to 
diabetes using a movement strategy as a cost-effective therapeutic 
intervention within the scope of physical therapist
f 
 
t 
 by 
ain.  Finally, we examined the 
effect of modifying FPA under barefoot conditions to observed changes 
influence of footwear.  Therefore, we cannot generalize these findings to the effect of FPA 
modification to in-shoe pressure measurements.  Future studies should confirm the impact of 
 practice.   
One of the limitations associated with this study is the small sample size.  Inclusion o
additional participants would have potentially brought the trending differences in the lateral mid
foot to statistical significance.  Another limitation is the heterogeneity of reported NPU location in 
the DMPN+NPU group.  Ulcer location may be indicative of the onset of rigid structural foo
deformities, thereby potentially limiting the magnitude of PPP reductions in the regions of 
interest.  In addition, FPA modification consisted of single session instruction, with 
measurements taken over several single steps.  Future studies could expand these findings
assessing the effects of changing FPA over multiple steps, and determining the effects of 
modifying FPA on other parts of the lower extremity kinetic ch
in PPP without the 
this type of gait modification strategy on in-shoe measurements of PPP.    
4.6. Conclusion 
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Our findings highlight the potential utility for FPA modification in adults with diabetes 
mellitus as a therapeutic intervention aimed at offloading areas of the plantar surface of the
at risk for NPU development.  Furthermore, we were able to reduce medial forefoot loading 
without creating excessive loads in other regions of the forefoot and mid foot.  Therefore, us
FPA reduction as a treatment strategy for offloading areas of the foot at risk for NPU 
development could be safely implemented in a physical therapist clinical practice. 
 foot 
ing 
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Table 4.1.  Participant characteristics, mean (SE).  VPT: vibration perception threshold 
(Volts); participants with a VPT greater than 25 Volts.  *:p<.05 
 
 
 
 
 
 
 
 
 
 
 DM (N=11) 
Mean (SE) 
DMPN+NPU (N=10) 
Mean (SE) 
p 
Age (years) 59 (3) 58 (3) .80 
Height (m) 1.7 (0.1) 1.7 (0.1) .70 
BMI (kg/m2) 34 (3) 40 (3) .09 
Duration of disease (years) 7 (2)* 24 (2) <.01 
R Great Toe VPT (volts) 15 (4)* 34 (4) <.01 
Walking speed (m/min) 58 (2)* 38 (3) <.01 
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Table 4.2.  Foot progression angle (FPA) magnitude on the involved (Inv) foot in both 
conditions for both groups.  Values are expressed in degrees, mean (SE).   Absolute 
FPA change (deg):  the absolute difference in FPA between conditions on the involved 
(Inv) foot; #able to correct: the number of participa hieve  clinically 
meaningful corrected change in FPA; # with ≥10⁰ in cFPA condition:  the number of 
particip e cFP ndition.
 
 
 
 
 
 
 DM  
(N=11) 
 
DMPN+NPU
(N=10)  
p 
Preferred FPA (pFPA, deg) -13 (2) -16 (2) .15 
Corrected FPA (cFPA, deg) 4 (3) -11 (4) <.01 
FPA change (deg) 16 (3) 9 (2) .14 
# able to correct >4⁰ 9 7 -- 
#with ≥10⁰ cFPA 2 5 -- 
nts able to ac  a
ants with an FPA ≥10⁰ for th A co  
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 Table 4.3.  Foot progression angle (FP eak pl essure ) covar
corre ted means for th  interaction effect of Condition (pFPA versus cFPA) 
(DM versus DMPN+NPU) x Mask A (Fore versus Mid) x Mask B (Lat versus Med) (p=.0.02). 
olumns represent the condition effect (within-group differences) in all variables, expressed in 
, 
g 
 Group pFPA cFPA p  
(condition) 
95% CI  
(Mean 
difference) 
  Mean (SE) Mean (SE)   
Walking Speed 
(m/min) 
     
 DM . 58 (2)* 57 (2)* 32 -2 to 4 
 DMPN+NPU 39 (5) 38 (4) .58 -3 to 6 
 ) <.01 <.01 p (Group  
FPA (deg)  
DM -13 (2)* 4 (3)* <.01 -23 to -10 
DMPN+NPU -16 (2) -11(4) .13 -13 to 2 
p (Group) .15 <.01  
Absolute FPA 
hange (deg)  c     
 DM 16 (3) N/A -2  to 15 
 N+NPU DMP 9 (2) N/A -2 to 14 
 p (Group) .14  
PPP Med Fore (N/cm2)  
 DM 44 (11) 30 (14) .07 -2 to 30 
 DMPN+NPU 64 (9) 59 (11) .24 -7 to 18 
 p (Group) .16 .12  
PPP Lat Fore (N/cm2)  
 DM 3 ) 30 (10)* .37 -5 to 17 6 (10
 DMPN+NPU 60 (8) 57 (8) .57 -6 to 11 
 p (Group) .08 .04  
PPP Med Mid (N/cm2)  
 DM 1 1 .99 -12 to 12 0 (1) 0 (6) 
 DMPN+NPU 8 (1) 11 (5) .55 -12 to 7 
 p (Group) .39 .88   
PPP Lat Mid (N/cm2)     
 DM 2 35 (12) .07 -28 to 1 1(10) 
 DMPN+NPU 26 (8) 31 (10) .32 -17 to 6 
 p (Group) .74 .83   
A) and p antar pr (PPP iance-
c e four-way x Group 
C
mean (SE).  Rows represent the group effect (between-group difference) in all variables
expressed in mean (SE).  pFPA: preferred FPA walking condition; cFPA: corrected FPA walkin
condition. Mask descriptions. Med Fore=medial forefoot; Lat Fore=lateral forefoot; Med 
Mid=medial mid foot; Lat Mid=lateral mid foot. Variable descriptions. FPA:  the value of foot 
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progression angle on the involved (Inv) foot for both groups under both walking conditions
Absolute FPA change: Absolute difference in FPA between conditions on the involved (Inv) foot. 
PPP: peak plantar pressure for each mask.    p (condition): significance values for the con
main effect, 95% CI of the average difference.  p (group): significance values for the group ma
effect, p<.05. 
 
 
 
.  
dition 
in 
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 Table 4.4.  Force-time integral (FTI) covariance-corrected means for the four-wa ion 
effec A versus cFPA) x  (DM Mask A (Fore 
versu  Mid) x Mask s M .02). C epresen  conditi  
ithin-group differences) in all variables, expressed in mean (SE).  Rows represent the group 
id 
t 
sk.    
.  
 Group pFPA cFPA p value 
(condition) 
95% CI  
(Mean 
difference) 
  Mean (SE) Mean (SE)   
FTI Med Fore (N*s)     
 DM 138 (42) 119 (40) .86 -15 to 53 
 DMPN+NPU 189 (33) 181(31) .54 -19 to 18 
 p (group) .35 .24  
FTI Lat Fore (N*s)  
 DM - 93 (22) 94 (21) .98 33 to 32 
 DMPN+NPU 136 (17) 128 (16) -18 to 33 .54 
 p (group) .15 .20  
FTI Med Mid (N s) *  
 DM 14 (8) 17 (19) .87 -44 to 38 
 DMPN+NPU 9 (6) 21 (15) .45 -44 to 20 
 p (group) .60 .89  
FTI Lat Mid (N*s)  
 DM 116 (37) 128 (35) .48 -47 to 23 
 DMPN+NPU 133 (29) 138 (28) .32 -17 to 6 
 p (group) .35 .23  
y interact
t of Condition (pFP Group versus DMPN+NPU) x 
s  B (Lat versu ed) (p=.0 olumns r t the on effect
(w
effect (between-group difference) in all variables, expressed in mean (SE).  pFPA: preferred 
FPA walking condition; cFPA: corrected FPA walking condition. Mask descriptions. Med 
Fore=medial forefoot; Lat Fore=lateral forefoot; Med Mid=medial mid foot; Lat Mid=lateral m
foot. Variable descriptions. FPA:  the value of foot progression angle on the involved (Inv) foo
for both groups under both walking conditions.  Absolute FPA change: Absolute difference in 
FPA between conditions on the involved (Inv) foot. PPP: peak plantar pressure for each ma
p (condition): significance values for the condition main effect, 95% CI of the average difference
p (group): significance values for the group main effect, p<.05. 
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Figure 4.1
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groups. pFPA: preferred FPA walking condition; cFPA: corrected FPA walking condition.  Mask 
. Med Fore=medial forefoot; Lat Fore=lateral forefoot; Med Mid=medial mid foot; 
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5.1. Summary 
Elevated regional peak plantar pressure (PPP) is an established index of risk dermal 
injury in adults with diabetes mellitus and peripheral neuropathy (DMPN)1,2, and is thought to 
initiate a lower extremity impairment cascade of medial neuropathic plantar ulcer (NPU) 
development and subsequent non-traumatic lower extremity amputation in individuals with 
DMPN. re 
 that 
ere 
e 
ere 
 
r 
 
t 
 
 
s 
  Foot progression angle (FPA) is a predictor of elevated regional PPP, a proxy measu
of dermal injury risk in adults with DMPN with and without a history of plantar ulceration1,3.   
Prior to this series of investigations, there were no longitudinal or cross-sectional studies
investigated specific characteristics of FPA in adults with DMPN.  Also, to our knowledge th
were no studies that identifying static or dynamic predictors of FPA in adults with DMPN.  
Finally, there were no studies probing whether excessive FPA is modifiable in adults with 
DMPN, thereby potentially creating a strategy for early rehabilitative intervention to interrupt th
cascade of lower extremity impairment leading to amputation4.  The primary objectives of this 
research were to determine if specific characteristics of FPA (magnitude and asymmetry) w
altered with disease progression and increasing severity of impairments (Aim 1), to identify
static and dynamic predictors of FPA magnitude (Aim 2), and to examine the effect of  reducing 
FPA on the regional plantar pressure distribution (Aim 3) in adults with and without DMPN.  Ou
first hypothesis was there would be a progressive increase in FPA magnitude and a progressive
decrease in the inter-limb FPA asymmetry across a spectrum of participants with and withou
DMPN and accompanying history of prior ulceration.  Our second hypothesis was that select 
static and dynamic predictor variables would explain a significant portion of the variance in FPA. 
Our third hypothesis was reduction of FPA in both groups would result in concomitant 
decreases in the magnitude of both regional force-time integral (FTI) and regional peak plantar
pressure (PPP) on the medial forefoot mask on the plantar surface of the foot.  The following i
a summary of the key findings and clinical relevance from each investigation. 
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5.1.a. Specific Aim 1. 
5.1.a.1. Key findings.  A detailed description of this investigation is outlined in Chapter 2.  One 
of the key findings from Aim 1 is that participants with diabetes mellitus and peripheral 
neuropathy with a reported history of prior ulceration (DMPN+NPU) had a greater FPA 
oups of older adults with and without DMPN.  
Another key finding from this investigation is there is no difference in the degree of asymmetry 
spatial characteristic of normal gait in adults 50 years or older.  
s, 
ipheral neuropathy potentially 
5.1.b.1. Key findings. A detailed description of all findings is outlined in Chapter 3.  One of the 
key findings from this study is that static (goniometric) measures of limited joint mobility of lower 
extremity joint motion are not predictors of FPA, whereas dynamic (gait kinematic and kinetic) 
dditionally, dynamic measures of the thigh and shank transverse plane 
of inter-segmental foot motion.   
magnitude on both feet than other participant gr
between groups, indicating that FPA asymmetry is not disease-specific, and may be a common 
5.1.a.2. Clinical relevance.  FPA is an established predictor of elevated regional plantar stres
a proxy measure of neuropathic plantar ulceration risk, in adults with DMPN with and without a 
history of NPU development1,3.    Although all groups met the criterion for having an excessive 
FPA (FPA>10⁰) in this study, a large FPA in the presence of per
exposes individuals with DMPN to elevated regional PPP and, subsequently, to risk for NPU 
development.  Therefore, there may be more clinical utility in the observation and measurement 
of FPA of both feet in adults with DMPN with and without a prior history of NPU development as 
part of an assessment of risk of NPU development or recurrence.   
5.1.b. Specific Aim 2. 
variables 37% of FPA.  A
motion during the mid stance phase of gait are better predictors of FPA than dynamic measures 
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5.1.b.2.  Clinical relevance.  These findings suggest rotation of segments proximal to the foot 
during gait may better predict FPA in older adults with DMPN.  Current interventions that target 
static and dynamic predictors of regional PPP within the scope of physical therapist practice are 
limited, and are often cost prohibitive5.  Identification of predictors of FPA could be clinically 
useful in assessing risk for elevated PPPs earlier in the lower extremity impairment cascade 
using tools that are widely available in most rehabilitation clinical settings (i.e., goniometers, 
5.1.c.1.  Key findings
investigation, two groups of participants with diabetes mellitus were able to achieve a clinically 
ude using a simple gait modification as the therapeutic 
strategy.  Another key finding of this study is the observed decrease in stress and load from the 
in mid foot stress and load in both groups.  This shift in regional stress is more pronounced in 
the DM group, which indicates that this particular gait modification strategy may more 
efficacious prior to the onset of peripheral neuropathy.    
rom this 
ar patterns of regional offloading in 
therapeutic intervention within the scope of physical therapist practice.   
5.2.a. FPA magnitude and asymmetry -
specific in a cross-section of individuals with and without diabetes, peripheral neuropathy, and a 
inked-moleskin method of gait analysis).     
5.1.c. Specific Aim 3. 
.  A detailed description of all findings is outlined in Chapter 4.  In this 
meaningful reduction of FPA magnit
medial forefoot, an area of the foot vulnerable to NPU development, and concomitant increase 
5.1.c.1. Clinical relevance.  In clinical practice, there are numerous treatment strategies for 
offloading plantar sites to promote wound healing or to prevent re-ulceration.  Results f
investigation demonstrate the potential for achieving simil
areas of the foot vulnerable to dermal injury in adults with DMPN using a cost-effective 
5.2. Study Limitations and Future Directions 
.  FPA magnitude, not inter-limb asymmetry, is disease
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prior history of ulceration.  Future studies should employ a longitudinal study design with more 
participants to better determine if there is a progressive increase in FPA magnitude in adults 
development of an excessive FPA could possibly facilitate treatment optimally before the 
initiation of the lower extremity impairment cascade of excessive medial peak plantar pressure 
(PPP), medial neuropathic plantar ulceration, and non-traumatic amputation.   
thigh 
 radiographic 
extend these findings by examining the radiographic static alignment factors in the proximal and 
distal segments of the lower extremity to determine if they also contribute to FPA.   
very brief 
series of single steps. Future studies could expand these findings by assessing the effects of 
FPA on other parts of the lower extremity kinetic chain.  Finally, we assessed  the effect of 
modifying FPA under barefoot conditions in order to measure FPA under similar  conditions.  
assessing in-shoe pressures and forces.  Future studies should examine the effects of this type 
of gait modification strategy on in-shoe measures of stress and load.  
with DMPN with and without a prior history of ulceration.  Determination of the onset of the 
5.2.b. Predictors of FPA.  Our investigation identified transverse rotation position of the 
and shank segments during the stance phase of gait as being the strongest predictors of FPA 
magnitude, irrespective of disease severity.  However, our study did not include
measures of lower extremity measures of static alignment.  Future studies could potentially 
5.2.c .Gait modification.  This study was the first to address the utility of reducing FPA (or 
positioning the foot closer to midline) as a gait modification strategy using simple visual and 
verbal cues.  However, this gait instruction and modification  was performed  over a 
changing FPA over multiple steps, and determining the effects of longer durations of modifying 
We cannot generalize our findings related to the effect of FPA modification to impact of footwear 
5.3. Conclusions 
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This dissertation research has identified specific characteristics and predictors of FPA.   
FPA is a predictor of elevated regional plantar stresses and loads in adults with and without 
s to characterize FPA in adults with increasing 
severity of impairments attributed to DMPN. This dissertation research provides new information 
on cha
ent 
 
 
 
 
 
 
 
DMPN.  This is the first series of investigation
racteristics and predictors of FPA, a risk factor for elevated regional PPP in adults with 
DMPN.  The clinical relevance of the findings from this dissertation research is the earlier 
identification of targets for earlier assessment and intervention in the lower extremity impairm
cascade that often culminates in non-traumatic lower extremity amputation in individuals with 
DMPN.  Furthermore, future studies could examine the efficacy of targeted physical therapy 
assessment tools and treatment strategies that may potentially address prevention versus 
treatment of NPU based on the unique features of FPA identified in this dissertation.   
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Figure 5.1.  Impairment cascade of non-traumatic lower extremity amputation 
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Appendix 1.  Mean (SD) and univariate correlation of foot progression angle (FPA) 
measurement using motion capture (Aim 1, Aim 2) and EMED pedobarograph (Aim 3) for a 
able 1A
subset of participants in the current study (N=21). 
 
 
 
T .  Pearson product moment correlation (r) between foot progression angle (FPA) 
values derived using EMED pedobarograph (EMED) and motion capture (MoCap).  
EMED/MoCap (right): the correlation coefficient  for FPA values derived using the EMED 
correlation coefficient  for FPA values derived using the EMED pedobarograph and motion 
capture (MoCap) for the left foot. 
able 1B
pedobarograph and motion capture (MoCap) for the right foot. EMED/MoCap (left): the 
 
 
 
 
T .  Mean (SD) of FPA values derived using the EMED pedobarograph and motion 
MoCap (right):  the mean (SD) for FPA values using motion capture (MoCap) for the right foot. 
EMED (left): the mean (SD) for FPA values using motion capture (MoCap) for the left foot. 
 
 EMED/MoCap (right) EMED/MoCap (left) p  
r 0.79 0.73 <.01 
 
EMED 
(right) 
MoCap 
(right) 
p 
(right) 
EMED 
(left) 
MoCap 
(left) 
p 
(left) 
FPA (deg) 0.17 0.58 -13 (4) -14 (7) -10 (4) -10 (5) 
capture.  EMED (right): the mean (SD) for FPA values derived using the EMED pedobarograph. 
MoCap (left):  the mean (SD) for FPA values using motion capture (MoCap) for the left foot.
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Figure 1A.  Scatter plots of average FPA values for both feet derived using the EMED 
pedobarograph (EMED) and using motion capture (MoCap) in the study population for all 
dissertation projects (N=21).   
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American Physical Therapy Association Combined Sections Meeting, Las Vegas, NV.  
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4. Merriwether EN, Host HH, and Sinacore DR. 2010. Sarcopenic indices and isokinetic 
peak torque measures as indicators of physical frailty.  Abstract for poster presentation 
at the Exercise and Physical Activity in Aging conference (EXPAAC), Indianapolis, IN.  
 
5. Merriwether EN, Hastings MK, Bohnert KL, Penelton K, Sinacore DR. 2011. Foot 
progression angle measurement using the Oxford Foot Model. Abstract accepted for 
podium presentation at Gait and Clinical Movement Analysis Society Annual Meeting, 
Bethesda, MD. 
 
6. Merriwether EN, Hastings MK, Bohnert KL, Penelton K, Sinacore DR. 2011. Comparison 
of three methods for measurement of foot progression angle (FPA) magnitude and 
asymmetry. Abstract accepted for poster presentation, American Society of 
Biomechanics. 
 
7. Merriwether, EN, Hastings MK, Bohnert KL, Sinacore DR. 2013. Impact of modification 
of foot progression angle on forefoot plantar loading. Abstract accepted for podium 
presentation, American Physical Therapy Association Combined Sections Meeting, San 
Diego, CA. 
 
8. Merriwether EN, Hastings MK, Bohnert KL, Sinacore DR. 2013. Asymmetry and 
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Annual Meeting, Cincinnati, OH. 
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1F31DK-088512  Merriwether (PI) 7/2012-6/2014    
NIH/NIDDK      $58,848 
Title:  Foot progression angle in individuals with diabetes mellitus and peripheral neuropathy 
The objective of this research is to determine the contribution of foot progression angle, a 
spatial gait variable that represents foot rotation in the transverse plane, to the development of 
neuropathic plantar ulcers in adults with diabetes mellitus and peripheral neuropathy.  
Role:  Principal Investigator  
 
Promotion of Doctoral Studies (PODS) II  8/31/2013-9/01/2013 
Foundation for Physical Therapy   $15,000 
Role:  Principal Investigator 
 
Completed 
 
Promotion of Doctoral Studies (PODS) I  8/31/2009-9/1/2011  
Foundation for Physical Therapy   $15,000 
This project sought to identify specific measures of foot and ankle motion during walking that 
could potentially be used to classify patients with diabetes mellitus and peripheral neuropathy as 
being at risk for the development of plantar ulcers and non-traumatic lower extremity 
amputation. 
Role:  Principal Investigator   
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CLINICAL EXPERIENCE 
 
Board Certifications 
• Certified Athletic Trainer, National Athletic Trainers’ Association  
• Certified Strength and Conditioning Specialist, National Strength and Conditioning 
Association  
Licensure 
• Missouri Physical Therapist #2008030517 
 
POSITIONS  HELD 
 
• Staff Athletic Trainer, Trident Sports Medicine and Rehabilitation.  
North Charleston, South Carolina, USA            2002-2005 
Provided injury evaluation, treatment, and referral for high school sports teams. 
• Physical Therapist Aide, Summerville Medical Center 
Summerville, South Carolina, USA       2005 
            Assisted in-patient physical therapists with transport and treatment. 
 
• Supplemental Athletic Trainer, Mayo Clinic Sports Medicine 
Rochester, Minnesota, USA             2005-2008 
Provided injury evaluation, treatment, and referral for select youth and adult 
sporting events. 
 
HONORS AND AWARDS 
 
2012  Edward Bouchet Graduate Honors Society, Washington University 
2012 Promotion of Doctoral Studies (PODS) II Scholarship, Foundation for Physical 
Therapy 
2010 Laura K. Smith Promotion of Doctoral Studies (PODS) I Scholarship, Foundation 
for Physical Therapy 
2009 Promotion of Doctoral Studies (PODS) I Scholarship, Foundation for Physical 
Therapy  
2008 Mayo Clinic Physical Therapy Alumni Association Academic Scholarship, Mayo 
Clinic 
2007-2008 Dr. Robert Waller Foundation Academic Scholarship/Clarence Day Foundation, 
Mayo Clinic 
1999 Applied Life Studies Continuation Academic Scholarship, University of Illinois at 
Urbana-Champaign 
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American Physical Therapy Association 
American Society of Biomechanics 
Gait & Clinical Movement Analysis Society 
International Society of Biomechanics 
 
 
SERVICE 
 
Manuscript Reviewer, Gait & Posture      2013-present 
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Executive Committee Member, Washington University in St. Louis   2011, 2013 
Graduate Council  
Member, Policies and Services Committee, Washington University in St. Louis 2010-present 
Vice-President, Black Graduate Council, Washington University in St. Louis 2011-present 
Departmental Student Representative, Graduate Council, Washington University 2009-present 
Minority and International Affairs liaison, Student Assembly, American  2007 
Physical Therapy Association 
Chair/Co-founder, Student Diversity Network, Mayo Clinic School   2006-2008 
of Health Sciences       
Representative, Student Alliance, Mayo Clinic School of Health Sciences  2006-2008 
Rochester Branch Secretary/Youth Advisor, National Association for the   2007-2008 
Advancement of Colored People (NAACP) 
 
 
 
